EurekaMag PDF full texts Chapter 31,476

Efange, S.M.N.; Mach, R.H.; Khare, A.B.; Michelson, R.H.; Nowak, P.A.; Evora, P.H. 1993: Fluorine-18 N-p-fluorobenzyltrozamicol FBT Molecular decomposition-reconstitution approach to novel vesamicol receptor radioligands. Journal of Nuclear Medicine 34(5 Suppl): 8P

Lastoria, S.; Varrella, P.; Mainolfi, C.; Piccolo, S.; Acampa, W.; Apicella, A.; Muto, P.; Thomas, R.; D'aiuto, G.; Panico, R.; Salvatore, M. 1997: Fluorine-18 PET imaging of primary breast cancer Preliminary results. Journal of Nuclear Medicine 38(5 Suppl): 234P

Monclus, M.; Biver, F.; Goldman, S.; Luxen, A. 1993: Fluorine-18 altanserine A short synthesis of the nitro precursor and preliminary metabolic studies in rat. Journal of Labelled Compounds and Radiopharmaceuticals 32: 523-524

Mulholland, G.K.; Winkle, W. 1995: Fluorine-18 and C-11 microparticles for absolute quantification by PET. Journal of Nuclear Medicine 36(5 Suppl): 69P

Rostom, A.Y.; Ezzat, A.; Powe, J.; Berry, J.; Jamshed, A.; Kandil, A.; Ahmed, G. 1996: Fluorine-18 deoxyglucose PET scan in breast cancer. British Journal of Cancer 74(Suppl 28): 33

Mukherjee, J.; Yang, Z.Y.; Perry, B.; Cooper, M. 1993: Fluorine-18 derivatives of 7-chloro-8-hydroxy-3-methyl-1- -2,3,4,5-tetrahydro-1H-3-benzazepine Selective and high affinity fluorinated radioligands for dopamine D-1 receptors. Journal of Labelled Compounds and Radiopharmaceuticals 32: 120-122

Mukherjee, J.; Yang, Z.Y.; Das, M.K.; Kronal, S.; Brown, T.; Cooper, M. 1993: Fluorine-18 fallypride as an improved PET radiotracer for dopamine D-2 receptors. Journal of Nuclear Medicine 34(5 Suppl): 234

Mukherjee, J.; Yang, Z.Y.; Perry, B.D.; Cooper, M. 1992: Fluorine-18 fluorinated derivatives of SCH 38548 as potential PET radiotracers for dopamine D-1 receptors. Investigative Radiology 27(12): 1120

Hwang, D.R.; Banks, W.R.; Borchet, R.; Mantil, J.C. 1993: Fluorine-18 fluorination of 3-pyrrolidinol A comparison of relative fluorine-18 fluorination rate of sulfonic esters of 3-pyrroldinol, and the unexpected fluorine-18 labeling of tresylate. Journal of Labelled Compounds and Radiopharmaceuticals 32: 104-105

Mulholland, G.K.; Kilbourn, M.R. 1993: Fluorine-18 fluoro-tert-butylbicyclo-o-benzoate A potential PET tracer for the GABA-A chloride channel. Journal of Labelled Compounds and Radiopharmaceuticals 32: 313

Guhike, S.; Coenen, H.H.; Stoecklin, G. 1993: Fluorine-18 fluoroacetic acid and fluoropropionic acid derivatives as reactive fluoroacylation agents. Journal of Labelled Compounds and Radiopharmaceuticals 32: 108-110

Zheng, L.; Berridge, M.S. 1993: Fluorine-18 fluoroacetone for radiopharmaceutical synthesis Preparation of fluorine-18 carazolol. Journal of Labelled Compounds and Radiopharmaceuticals 32: 296-297

Guhlke, S.; Wester, H.J.; Bruns, C.; Stoecklin, G. 1993: Fluorine-18 fluoroacylated octreotide for quantitative somatostatin receptor imaging with PET. Journal of Nuclear Medicine 34(5 Suppl): 80P

Khong, P.-L.; Pang, C.B.Y.; Liang, R.; Kwong, Y.-L.; Au, W.-Y. 2008: Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Annals of Hematology 87(8): 613-621

Seo, S.; Hatano, E.; Higashi, T.; Nakajima, A.; Nakamoto, Y.; Tada, M.; Tamaki, N.; Iwaisako, K.; Mori, A.; Doi, R.; Ikai, I.; Uemoto, S. 2008: Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery 143(6): 769-777

Yeh, S.H.; Wu, L.C.; Liu, R.S.; Yang, D.J.; Yen, S.H.; Yu, T.W.; Chang, C.W.; Chen, K.Y. 1994: Fluorine-18 fluoromisonidazole -FMISO tumor Muscle retention ratio in detecting hypoxia in nasopharyngeal carcinoma. Journal of Nuclear Medicine 35(5 Suppl): 142P

Goodman, M.M.; Keil, R.; Shi, B.; Shoup, T.; Eshima, D.; Shattuck, L.; Votaw, J.; Camp, V.; Votaw, D.; Malveaux, E.; Huerkamp, M.; Hoffman, J.M. 1995: Fluorine-18 labeled 2-beta-carbo-2-fluoroisopropoxy-3-beta- tropane Synthesis and primate imaging of a potential radioligand for quantitating dopamine transporter density by PET. Journal of Nuclear Medicine 36(5 Suppl): 38P

Keil, R.; Goodman, M.M.; Shoup, T.; Eshima, D.; Shattuck, L.; Votaw, J.; Camp, V.; Votaw, D.; Malveaux, E.; Huerkamp, M.; Hoffman, J.M. 1995: Fluorine-18 labeled 2-beta-carbomethoxy-3-beta- -8- nortropane Synthesis and tissue distribution of a potential radioligand for mapping cocaine receptor sites by PET. Journal of Nuclear Medicine 36(5 Suppl): 153P-154P

Shiue, C.Y.; Bai, L.Q.; Shiue, G.G.; Rysavy, J.A.; Pleus, R.C.; Huang, H.; Frick, M.P.; Catt, J.D.; Yevich, J.P. 1993: Fluorine-18 labeled BMY 14802 Synthesis and anatomical distribution in rodents. Journal of Labelled Compounds and Radiopharmaceuticals 32: 501-503

Garg, P.K.; Garg, S.; Welsh, P.C.; Zalutsky, M.R. 1993: Fluorine-18 labeled analogs of m-iodobenzylguanidine. Journal of Labelled Compounds and Radiopharmaceuticals 32: 544-546

Van Dort, M.E.; Jung, Y.W.; Kilbourn, M.R.; Sherman, P.S.; Pisani, T.L.; Wieland, D.M. 1992: Fluorine-18 labeled biogenic amines Potential radiotracers for adrenergic neuronal mapping by PET. Society for Neuroscience Abstracts 18(1-2): 23

Channing, M.A.; Lang, L.; Jagoda, E.; Vera, D.; Eckelman, W.C. 1997: Fluorine-18 labeled biotin analogs Potential ligands for antibody-streptavidin conjugates. Journal of Nuclear Medicine 38(5 Suppl): 142P

Vaidyanathan, G.; Affleck, D.A.; Welsh, P.; Zalutsky, M.R. 1994: Fluorine-18 labeled chemotactic peptide A potential agent for the PET imaging of focal infection. Journal of Labelled Compounds and Radiopharmaceuticals 35: 365-367

Van Brocklin, H.F.; Enas, J.D.; Hanrahan, S.M.; O'neil, J.P. 1995: Fluorine-18 labeled dihydrorotenone analogs Preparation and evaluation of PET mitochondrial probes. Journal of Labelled Compounds and Radiopharmaceuticals 37: 217-219

Dolle, F.; Kuhnast, B.; Terrazzino, S.; Tavitian, B.; Hinnen, F.; Vaufrey, F.; Crouzel, C. 1997: Fluorine-18 labeled oligodeoxynucleotides for in vivo PET imaging. Journal of Labelled Compounds and Radiopharmaceuticals 40: 4-6

Katzenellenbogen, J.A. 1995: Fluorine-18 labeled steroids for imaging receptor-positive tumors by positron emission tomography Synthesis, binding, distribution, and metabolism. Abstracts of Papers American Chemical Society 210(1-2): MEDI 109

Aloj, L.; Lang, L.; Eckelman, W.C. 1995: Fluorine-18 labeled transferrin for measuring tumor metabolism. Journal of Nuclear Medicine 36(5 Suppl): 38P-39P

Vaidyanathan, G.; Affleck, D.J.; Welsh, P.C.; Slade, S.A.; Alston, K.L.; Zalutsky, M.R. 1996: Fluorine-18 labeling of -alpha-MSH, an alpha-melanocyte stimulating hormone analogue. Journal of Nuclear Medicine 37(5 Suppl): 191P

Vanbrocklin, H.F.; Enas, J.D.; Garcia, J.G.; Hanrahan, S.M. 1994: Fluorine-18 labelled indanones and indandiones Intermediates for the production of indan radiopharmaceuticals. Journal of Labelled Compounds and Radiopharmaceuticals 35: 169-170

Rogers, G.; Steone Elander, S.; Eriksson, L.; Ingvar, M.; Parsons, S.; Widen, L. 1993: Fluorine-18 vesamicol derivatives for in vivo evaluation as tracers for cholinergic synaptic vesicles. Journal of Labelled Compounds and Radiopharmaceuticals 32: 486

Burgers, J.A.; Valkema, R.; Van Meerbeeck, J.P.A.M.; Reijs, A.E.M.; Krenning, E.P. 1998: Fluorine-18-deoxyglucose coincidence ECT for the detection of non-small cell lung cancer. European Respiratory Journal 12(Suppl 28): 302S

Valkema, R.; Romijn, M.G.; Van Eijck, C.H.J.; Reijs, A.E.M.; Van Peski, J.; Krenning, E.P. 1997: Fluorine-18-deoxyglucose single photon emission tomography for the detection of pancreatic cancer. Journal of Nuclear Medicine 38(5 Suppl): 246P

Schmidt, K.C.; Lucignani, G.; Sokoloff, L. 1996: Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 37(2): 394-399

Lee, S.K.; Kabalka, G.W. 1997: Fluorine-18-labeled carboranes for use in PET imaging of BNCT agents containing carboranes. Larsson, B, Crawford, J, Weinreich, R International Congress Series; Advances in neutron capture therapy, Vol II, chemistry and biology 299-301

Narayanasami, R.; Horowitz, P.M.; Masters, B.S.S. 1993: Fluorine-19 NMR and fluorescence spectroscopy to study structure-function relationships in NADPH-cytochrome P450 reductase. FASEB Journal 7(7): A1205

Mabury, S.A.; Crosby, D.G. 1993: Fluorine-19 NMR as an analytical tool for monitoring fluorinated pesticides. Abstracts of Papers American Chemical Society 206(1-2): AGRO 87

Liu, R.S.H.; Colmenares, L.U. 1992: Fluorine-19 NMR in studies of fluorinated visual pigment analogs A method for detecting neighbouring groups or empty space in a binding site. Rigaud, Journal -L INSERM Colloquium; Structures and functions of retinal proteins Colloque INSERM; Structures et fonctions des retino-proteines : 251-254

Sun, Z.Y.; Pratt, E.A.; Truong, H.T.N.; Sutherland, D.; Kulig, C.; Homer, R.J.; Ho, C. 1993: Fluorine-19 NMR investigation of membrane-binding domain of D-lactate dehydrogenase of Escherichia coli. Biophysical Journal 64(2 Part 2): A286

Liu, R.S.H.; Colmenares, L.U.; Niemczura, W. 1993: Fluorine-19 NMR studies of fluorinated visual pigment analogs. Shima, A, Ichahashi, M, Fujiwara, Y, Takebe, H International Congress Series; Frontiers of photobiology: 171-172

London, R.E.; Gabel, S.A. 1994: Fluorine-19 NMR studies of fluorobenzeneboronic acids 1 Interaction kinetics with biologically significant ligands. Journal of the American Chemical Society 116(6): 2562-2569

London, R.E.; Gabel, S.A. 1994: Fluorine-19 NMR studies of fluorobenzeneboronic acids 2 Kinetic characterization of the interaction with subtilisin Carlsberg and model ligands. Journal of the American Chemical Society 116(6): 2570-2575

Anderson, S.J.; Herbert, B.E. 1993: Fluorine-19 NMR study of molecular interactions between polar aromatic solutes and humic acid. Abstracts of Papers American Chemical Society 205(1-2): ENVR2

Mcintyre, D.D.; Yuan, T.; Luykx, A.; Vogel, H.J. 1996: Fluorine-19 and proton NMR studies of difluoromethionine calmodulin. Progress in Biophysics and Molecular Biology 65(Suppl 1): 33

Lee, D.J.; Burt, C.T.; Koch, R.L. 1992: Fluorine-19 magnetic resonance spectroscopy using one dimensional linear gradient chemical shift imaging technique to determine local drug concentration In vitro phantom study simulating skin. Pharmaceutical Research (New York) 9(10 Suppl): S187

Petersson, K.G.; Larsson, E. 1993: Fluorine-clearance in human saliva after use of fluorine-toothpicks and fluorine tablets. Journal of Dental Research 72(Special Issue): 271

Takeuchi, T.; Umezawa, S.; Tsuchiya, T.; Takagi, Y.; Sohtome, H. 1998: Fluorine-containing anthracycline derivatives having hydroxyl groups mono- or di-O-aminoalkanoylated in the sugar moiety thereof. Official Gazette of the United States Patent and Trademark Office Patents 1213(1): 607

Dorsch, D.; Baumgarth, M.; Gericke, R.; Minck, K O.; Beier, N. 1998: Fluorine-containing benzoylguanidines. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 529

Katayama, M.; Fujii, S.; Kimoto, H.; Kato, K. 1996: Fluorine-containing beta-indolebutyric acid compounds, and regulation of plant growth therewith. Official Gazette of the United States Patent and Trademark Office Patents 1184(1): 399

Platzek, J.; Raduechel, B.; Niedballa, U.; Weinmann, H J.; Bauer, H.; Roth, K. 1997: Fluorine-containing macrocyclic metal complexes. Official Gazette of the United States Patent and Trademark Office Patents 1204(4): 2994

Schroeder, H.F. 1992: Fluorine-containing surfactants A further challenge for the environment? Part 2 Nonionic surfactants. Fachgruppe Wasserchemie In Der Gesellschaft Deutscher Chemiker. Vom Wasser: 211-227

Bollens, E.; Mahieu, C. 1995: Fluorine-containing, polyglycerolated amphiphilic sulphur compounds, cosmetic or pharmaceutical composition containing them, preparation process and vesicles formed. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1834

Wedzisz, A. 1994: Fluorine-environment-food. Bromatologia i Chemia Toksykologiczna 27(4): 347-352

Shinoki, N.; IIda, T. 1998: Fluorine-substituted ganglioside GM3 derivative and intermediates therefor. Official Gazette of the United States Patent and Trademark Office Patents 1213(1): 655

Allison, W.S. 1981: Fluoro 2 4 dinitro benzene modifies a tyrosine residue when it inactivates the bovine mitochondrial f 1 atpase. Biochemical and Biophysical Research Communications: 813-819

Wang B Y.; Lin L Y. 1989: Fluoro densitometric quantitative determination of gentamicin c components in fermentation broth. Zhongguo Kanfshengsu Zazhi 14(1): 57-58

Schmued, L. 1990: Fluoro gold and 4 acetamido 4 isothiocyanostilbene 2 2 disulfonic acid use of substituted stilbenes in neuroanatomical studies. Conn, P M Methods in Neurosciences, Vol 3 Quantitative And Qualitative Microscopy Xv+494p Academic Press, Inc : San Diego, California, Usa Illus 317-330

Averill, D.B.; Diz, D.I.; Andreatta Van Leyen, S.H. 1989: Fluoro gold does not alter angiotensin ii binding in the dorsomedial medulla of the rat. Society for Neuroscience Abstracts 15(2): 989

Burger, K.; Wucherpfennig, U.; Brunner, E. 1994: Fluoro heterocycles with five-membered rings. Katritzky, A R Advances in Heterocyclic Chemistry 1-64

Quinn, B. 1989: Fluoro nissl green purification and functional characterization of a novel fluorescent nissl stain for neuroanatomic techniques. Society for Neuroscience Abstracts 15(1): 309

Reddy, A.C. Sheker; Rao, P.S.; Venkataratnam, R.V. 1996: Fluoro organics A facile and exclusive synthesis of novel 2- or 4-trifluoromethyl arylodiazepines. Tetrahedron Letters 37(16): 2845-2848

Ali, S.M.; Babu, Y.S.; Bantia, S.; Chand, P.; Chu, N.; Montgomery, J.A.; Walsh, D.A.; Luo, M.; Brouillette, W.J. 1997: Fluoro substituted aromatic inhibitors of influenza neuraminidase. Abstracts of Papers American Chemical Society 213(1-3): MEDI 277

Deluca, H.F. 1979: Fluoro vitamin d 3 a vitamin d 3 analog more active on bone calcium mobilization than on intestinal calcium transport. Biochemistry: 1641-1646

Chaise, C.; Itti, E.; Petegnief, Y.; Wirquin, E.; Copie-Bergman, C.; Farcet, J.-Pierre; Delfau-Larue, M.-Helene; Meignan, M.; Talbot, J.-Noel; Molinier-Frenkel, V. 2000: Fluoro-2-deoxy-D-glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunology Immunotherapy 56(8): 1163-1171

Vaidyanathan, G.; Affleck, D.J.; Zalutsky, M.R. 1994: (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography. Journal of Medicinal Chemistry 37(21): 3655-3662

Schmued, L.C.; Slikker, W.Jr.; Wang, G.J. 1998: Fluoro-Jade B A bis homolog of Fluoro-Jade with improved degenerate neuron staining properties. Society for Neuroscience Abstracts 24(1-2): 1064

Zhu, W.; Dey, R. 1995: Fluoro-Ruby as an anterograde and retrograde axonal marker for the study of ferret paratracheal parasympathetic ganglia. FASEB Journal 9(4): A698

Schmued, L.C.; Bowyer, J.F.; Beltramino, C.; Broening, H.W.; Slikker, W.Jr 1992: Fluoro-gold revisited Toxicological and pharmacological properties. Society for Neuroscience Abstracts 18(1-2): 1126

Furuta, S.; Kuroboshi, M.; Hiyama, T. 1995: Fluoro-pummerer rearrangement under oxidative desulfurization fluorination conditions Facile synthesis of oligofluoroalkyl sulfides. Tetrahedron Letters 36(45): 8243-8246

Hamprecht, G.; Fuchs, E.; Gerber, M.; Walter, H.; Westphalen, K O. 1998: Fluoro-pyridine-2,3-dicarboxylic anhydrides which are intermediates for herbicidal pyridine-2,3-dicarboximides. Official Gazette of the United States Patent and Trademark Office Patents 121(4): 4068

Kraynov, S.R.; Mer kov A.N.; Petrova, N.G.; Baturinskaya, I.V.; Zharikova, V.M. 1969: Fluoro-silicate brines with strong alkaline reaction pH 12 from the Lovozero massif. Geokhimiya 7: 791-796

Meyer, J.J.M.; Van Rooyen, S.W. 1994: Fluoroacetate metabolism by a bacterium from Dichapetalum braunii. Colegate, S M, Dorling, P R Plant-associated toxins: Agricultural, phytochemical and ecological aspects 457-461

Ruminski, P.G. 1995: Fluoroalkenyl compounds and their use as pest repellents. Official Gazette of the United States Patent and Trademark Office Patents 1179(2): 1084-1085

Amschler, H. 1998: Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1206(4): 2973

Lowe, J.A.IIi; Rosen, T.J. 1998: Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles. Official Gazette of the United States Patent and Trademark Office Patents 1211(5): 5051-5052

Husek, P.; Simek, P.; Hartvich, P.; Zahradnícková, H. 2008: Fluoroalkyl chloroformates in treating amino acids for gas chromatographic analysis. Journal of Chromatography. a 1186(1-2): 391-400

Riess, J.G.; Vierling, P.; Garelli, N. 1997: Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses. Official Gazette of the United States Patent and Trademark Office Patents 1200(3): 2110-2111

Basi, N.S.; Toyoshige, M.; Rebois, R.V.ctor 1995: Fluoroaluminate activates G-s without causing subunit dissociation. FASEB Journal 9(6): A1410

Gimes, G.; Toth, M.; Laszlo, A. 1996: Fluoroaluminate selectively stimulates phosphatidylcholine turnover in the human primordial placenta. FASEB Journal 10(3): A416

Menchini, U.; Ferrari, E.; Lanzetta, P. 1994: Fluoroangiographic abnormalities of the iris related to glaucoma in pseudoexfoliation syndrome. IOVS Investigative Ophthalmology and Visual Science 35(4): 1853

Negash, K.; Morton, T.E.; Vanbrocklin, H.F. 1997: Fluorobenzyltrozamicol An efficient synthetic approach. Journal of Labelled Compounds and Radiopharmaceuticals 40: 40-42

Egeland, G.; Bloom, T.; Schnorr, T.; Hornung, R.; Suruda, T. 1991: Fluorocarbon 113 exposure and dysrhythmias among aerospace workers. American Journal of Epidemiology 134(7): 742-743

Unger, E.; Fritz, T.; Matsunaga, T.; Barrette, T.; Mccreery, T. 1994: Fluorocarbon Gas Filled Lipid Bilayers Hemodynamic and Ultrasonic Imaging in Dogs. Circulation 90(4 Part 2): I534

Segel, L.D. 1994: Fluorocarbon blood substitute. Official Gazette of the United States Patent and Trademark Office Patents 1169(3): 1723

Obraztsov, V.V. 1994: Fluorocarbon blood substitutes in Russia. Artificial Cells Blood Substitutes and Immobilization Biotechnology 22(4): 1019-1027

Rozzi, S.M.; Mitra, S.B.; Kedrowski, B.L.; Shelburne, C.E. 1997: Fluorocarbon containing coatings compositions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 355

Mellul, M.; Arnaud, P. 1998: Fluorocarbon continuous phase water-in-oil emulsions employing silicone surfactants. Official Gazette of the United States Patent and Trademark Office Patents 1217(4): 3281

Kirkland, W.D. 1996: Fluorocarbon contrast media for use with MRI and radiographic imaging. Official Gazette of the United States Patent and Trademark Office Patents 1184(1): 329

Marchbank, A. 1995: Fluorocarbon emulsions. Perfusion 10(2): 67-88

Voynikov, T.I.; Nikolova, I.N.; Suzuki, A.; Higashino, H. 1990: Fluorocarbon emulsions application in cerebral and other forms of ischemia. Neurosciences 16(4): 591-602

Weers, J.G.; Schutt, E.G.; Pelura, T.J.; Keipert, P.E. 1997: Fluorocarbon emulsions with reduced pulmonary gas-trapping properties. Official Gazette of the United States Patent and Trademark Office Patents 1199(1): 435-436

Mouton, G. 1991: Fluorocarbon refrigerants and the environment. International Journal of Refrigeration 14(4): 209-216

Clark, L.C.Jr; Hoffmann, R.E.; Fouraker, S.L.; Spokane, R.B.; Miller, M. 1989: Fluorocarbon vapor dynamics and hyperinflated lung in the rabbit. FASEB Journal 3(3): A685

Blair, T.L.; Cynkowski, T.; Bachas, L.G. 1993: Fluorocarbon-based immobilization of a fluoro ionophore for preparation of fiber optic sensors. Analytical Chemistry 65(7): 945-947

Riess, J.G. 1998: Fluorocarbon-based oxygen-delivery Basic principles and product development. Chang, T M S Tissue Engineering; Blood substitutes: Principles, methods, products and clinical trials, Vol 2 101-126

Fuhrman, B.P.; Flaim, S.F.; Hernan, L.J.; Nesti, F.D.; Papo, M.C.; Steinhorn, D.M. 1995: Fluorocarbons as anti-inflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1180(4): 2572

Stern, R.G.; Shaffer, T.H.; Wolson, M.R. 1998: Fluorochemical liquid augmented cryosurgery. Official Gazette of the United States Patent and Trademark Office Patents 1209(3): 2202

Kauffman, J.M.; Westerman, P.W.; Leonard, M.R.; Kulkarni, V.S.; Crawford, J.M.; Carey, M.C. 1998: Fluorocholesterols Synthesis and physical-chemical characterization of promising analogs for tracking cholesterol movement through hepatocytes. Hepatology 28(4 Part 2): 533A

Kubbies, M. 1990: Fluorochrome binding and cell viability apoptosis recognized by flow cytometry. Cell Biology International Reports 14(ABSTR Suppl): 77

Wykretowicz, A.; Garbin, F.; Eckert, K.; Maurer, H.R.; Wysocki, H. 1993: Fluorochrome labeling of polymorphonuclear and mononuclear cells for measurement of adherence to human umbilical vein endothelial cells and plastic surface. Immunologia Polska 18(1): 69-79

Ratinaud, M.H.; Petit, J.M.; Cognard, C. 1994: Fluorochromes used in cytometry and precautions for their utilization. Metezeau, P, Ratinaud, M -H, Carayon, P, Techniques in: Fluorescence cytometry: Comparative evaluation of flow, imaging and confocal techniques, Techniques en: Cytometrie par fluorescence: Apports comparatifs des techniques flux, image et confocale 35-80

Elliott, A.S.; Nunez, A.A. 1995: Fluorocitrate affects circadian rhythms in rats. Society for Neuroscience Abstracts 21(1-3): 1678

Imamura, K.; Muguruma, K.; Watanabe, Y. 1994: Fluorocitrate depressed cAMP response to noradrenaline perfusion in microdialysis. Japanese Journal of Physiology 44(Suppl 1): S214

Gwag, B.J.; Kemmerer, K.; Robin, V.; Lehmann, J.; Sessler, F.M.; Springer, J.E. 1993: Fluorocitrate, a metabolic inhibitor of glial function, induces NGF and BDNF mRNA in the rat hippocampal formation. Society for Neuroscience Abstracts 19(1-3): 257

Wiebe, L.I.; Diakur, J. 1998: Fluorocyclosaccharide drug delivery systems. Official Gazette of the United States Patent and Trademark Office Patents 1209(2): 1423

Canfarini, F.; Giolitti, A.; Guidi, A.; Pasqui, F.; Pestellini, V.; Arcamone, F. 1993: Fluorodehydroxylation of anthracyclinones with DAST synthesis of 8- -fluorodaunorubicin. Tetrahedron Letters 34(29): 4697-4700

Novaković, J.; Agbaba, D.; Stakić, Z. 1989: Fluorodensitometric determination of conjugated estrogens in raw material and in pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis 7(12): 1657-1662

Agbaba, D.; Ivanovic, S.; Zivanov Stakic, D. 1991: Fluorodensitometric determination of plasma and urinary testosterone. Journal of Planar Chromatography - Modern TLC 4(3): 267-269

Goldberg, M.A.; Lee, M.J.; Fischman, A.J.; Mueller, P.R.; Alpert, N.; Thrall, J.H. 1993: Fluorodeoxyglucose PET applications in the abdomen and pelvis Potential role in oncologic imaging. Journal of Nuclear Medicine 34(5 Suppl): 260P

Liu, R.S.; Yen, M.Y.; Yen, T.C.; Chu, L.S.; Chang, C.P.; Chou, K.L.; Wang, J.K.; Wu, L.C.; Yeh, S.H. 1995: Fluorodeoxyglucose PET imaging in Lebers hereditary optic neuropathy. Journal of Nuclear Medicine 36(5 Suppl): 246P

Molloy, P.T.; Sadek, A.H.; Vaughan, S.N.; Quinn, K.B.; Needle, M.N.; Phillips, P.C.; Alavi, A. 1996: Fluorodeoxyglucose PET in pediatric patients with neurofibromatosis type 1. Journal of Nuclear Medicine 37(5 Suppl): 265P

Welch, M.J.; Bonasera, T.A.; Sherman, E.L.C.; Katzenellenbogen, J.A.; Dehdashti, F.; Siegel, B.A. 1995: Fluorodeoxyglucose and 16-alpha- fluoroestradiol-17-beta uptake in estrogen-receptor -rich tissues following tamoxifen treatment A preclinical study. Journal of Nuclear Medicine 36(5 Suppl): 39P

Reinhardt, M.; Kubota, K.; Yamada, S.; Moser, E. 1996: Fluorodeoxyglucose and L-methionine in the assessment of cancer recurrence. Journal of Nuclear Medicine 37(5 Suppl): 67P-68P

Slosman, D.O.; Pittet, N.; Polla, B.S. 1992: Fluorodeoxyglucose cell uptake as an index of cell proliferation rate in vitro evaluation. European Journal of Nuclear Medicine 19(8): 702

Herholz, K.; Friedrich, B.; Heiss W D. 1991: Fluorodeoxyglucose pet and prognosis of low grade glioma. Journal of Nuclear Medicine 32(5 Suppl): 932

Pascal, S.; Resnick, L.; Yoshii, F.; Chang, J.; Barker, W.; Apicella, A.; Boothe, T.; Duara, R. 1990: Fluorodeoxyglucose pet scan metabolic asymmetries in asymptomatic hiv seropositive subjects correlation with disease onset. Journal of Nuclear Medicine 31(5 Suppl): 826

Molloy, P.T.; Alavi, A.; Needle, M.N.; Vaughan, S.N.; Wang, Z.; Hoydu, A.K.; Zimmerman, R.A.; Phillips, P.C. 1995: Fluorodeoxyglucose position emission tomography , magnetic resonance spectroscopy and dynamic perfusion MRI in the study of optic pathway tumors and brainstem tumors in neurofibromatosis type I. Journal of Nuclear Medicine 36(5 Suppl): 191P-192P

Burra, P.; Pizzolato, G.; Chierichetti, F.; Tedeschi, U.; D'inca, R.; Fagiuoli, S.; Floreani, A.; Pittoni, G.; Dam, M. 1998: Fluorodeoxyglucose positron emission tomography and neuropsychological study before and after liver transplantation. Journal of Hepatology 28(Suppl 1): 68

Burra, P.; Pizzolato, G.; Mantovan, M.C.; Cagnin, A.; Chierichetti, F.; Boccagni, P.; Fagiuoli, S.; Naccarato, R.; Dam, M. 1996: Fluorodeoxyglucose positron emission tomography to measure cortical functional impairment in patients with end-stage liver disease without neurological abnormalities. Gastroenterology 110(4 Suppl): A1160

Amaravadi, R.R.; Behr, S.C.; Kousoubris, P.D.; Raja, S. 2008: Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia. AJNR 29(6): 1197-1199

Arredondo, M.A.; Yin M B.; Rustum, Y.M. 1991: Fluorodeoxyuridine induces dna damage and g 2 m arrest. Proceedings of the American Association for Cancer Research Annual Meeting 32: 28

Lawrence, T.S.; Davis, M.A.; Tang, H.Y.; Maybaum, J. 1992: Fluorodeoxyuridine mediated radiosensitization of human colon cancer cells is not caused by cell cycle redistribution. Proceedings of the American Association for Cancer Research Annual Meeting 33: 502

Vanbrocklin, H.F.; Enas, J.D.; Hanrahan, S.M.; Brennan, K.M.; O'neil, S.P.; Taylor, S.E. 1994: Fluorodihydrorotenone Synthesis and evaluation of a mitochondrial electron transport chain complex I probe for PET. Journal of Nuclear Medicine 35(5 Suppl): 73P

Snow, B.J.; Vingerhoets, F.J.G.; Schulzer, M.; Calne, D.B.; Freeman, T.; Olanow, C.W. 1994: Fluorodopa PET evolution of bilateral striatal fetal mesencephalic graft for idiopathic Parkinsonism. Neurology 44(4 Suppl 2): A281

Takahashi, H.; Snow, B.; Nygaard, T.; Yokochi, M.; Calne, D. 1995: Fluorodopa PET scans of juvenile Parkinsonism with prominent dystonia in relation to dopa-responsive dystonia. Segawa, M, Nomura, Y Monographs in Neural Sciences; Age-related dopamine-dependent disorders 87-94

Chalv, T.; Ishikawa, T.; Dhawan, V.; Robeson, W.; Margouleff, C.; Margouleff, D.; Eidelberg, D. 1995: Fluorodopa positron emission tomography with an inhibition of catechol-O-methyltransferase Effect of the plasma 3-O-methyldopa fraction on data analysis. Journal of Nuclear Medicine 36(5 Suppl): 128P

Chan, A.D.C.; Boden, M.W.; Benco, J.S.; Bergquist, R.A.; Orvedahl, D.S. 1997: Fluoroelastomer gasket for blood sensors. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 2944-2945

Tewson, T.J.; Mankoff, D.A.; Petra, P.; Woo, I.; Peterson, L.M. 1998: Fluoroestradiol Binding to sex steroid binding protein. Journal of Nuclear Medicine 39(5 Suppl): 35P

Yang, D.J.; Liu, C.W.; Kuang, L.R.; Tansey, W.; Li, S.C.; Gretzer, M.B.; Cherif, A.; Li, C.; Wallace, S. 1994: Fluoroethyluracil Synthesis, cell proliferation assay, biodistribution and PET imaging in tumor-bearing animals. Pharmaceutical Research (New York) 11(10 Suppl): S119

Desmurs, J.R.; Forat, G.; Mas, J.M.; Pevere, V.; Ratton, S.; Roques, N.; Russel, J.; James, L.S.int 1997: Fluoroform and trifluoroacetic acid Sources of trifluoromethyl groups Access to derivatives of triflic acid. Abstracts of Papers American Chemical Society 213(1-3): AGRO 9

Quante, J.M.; Hoke, R.A.; Mize, P.D.; Woodard, D.L.; Millner, O.E. 1996: Fluorogenic and chromogenic beta-lactamase substrates. Official Gazette of the United States Patent and Trademark Office Patents 1193(2): 1300-1301

Mullen, E.A.; Mckee, M.D.; Hauschka, P.V. 1989: Fluorogenic assay of proteinase activity in developing rat enamel. Journal of Dental Research 68(Special Issue): 239

Habenstein, K. 1996: Fluorogenic compounds and their use. Official Gazette of the United States Patent and Trademark Office Patents 1193(3): 2052

Wang, G.T.; Matayoshi, E.; Erickson, J.W.; Krafft, G.A. 1990: Fluorogenic determination of structural requirements for hiv protease substrates. St Georgiev, V And J J Mcgowan (Ed ) Annals Of The New York Academy Of Sciences, Vol 616 Aids: Anti-Hiv Agents, Therapies, And Vaccines; Second International Conference on Drug Research in Immunologic And Infectious Diseases: Acquired Immune Deficiency Syndrome (Aids), Arlington, Virginia, Usa, November 6-9, 1989 Xv+634p New York Academy Of Sciences: New York, New York, Usa Illus 617-619

Zhou, M. 1998: Fluorogenic ovalbumin for assaying antigen processing in live cells. FASEB Journal 12(4): A589

Angleton, E.L.; Nagase, H.; Birkedal-Hansen, H.; Van Wart, H.E. 1992: Fluorogenic peptide substrates optimized for five human matrix metalloproteinases. Matrix . Suppl 1: 89-90

Gallagher, M.; Morris, T.; Holloway, B.; Robertson, B. 1997: Fluorogenic probe based PCR assay which targets the 5 untranslated region of hepatitis G virus RNA. Abstracts of the General Meeting of the American Society for Microbiology 97: 149

Matuszewski, B.K.; Bayne, W.F. 1989: Fluorogenic reaction between adenine derivatives and chloroacetaldehyde and its application to the determination of 9 2 chloro 6 fluorobenzyladenine in human plasma. Analytica Chimica Acta 227(1): 189-202

Del Castillo, B.; Alvarez Builla, J.; Lerner, D.A. 1991: Fluorogenic reagents and fluorescent probes. Baeyens, W R G , D De Keukeleire And K Korkidis (Ed ) Practical Spectroscopy Series, Vol 12 Luminescence Techniques in Chemical And Biochemical Analysis Xvii+654p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 73-140

Ohkura, Y.; Nohta, H. 1992: Fluorogenic reagents for the derivatization of catecholamines and related compounds for liquid chromatographic analysis of biological samples. Trends in Analytical Chemistry 11(2): 74-79

Imai, K.; Uzu, S.; Toyo'oka, T. 1989: Fluorogenic reagents, having benzofurazan structure, in liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 7(12): 1395-1403

Herzenberg, A. 1989: Fluorogenic reporter gene analysis and sorting of viable cells. Journal of Cellular Biochemistry Suppl (13 Part D): 2

Klingel, S.; Ganesh, S.; Kahle, H.; Valet, G. 1994: Fluorogenic rhodamine110 substrates for the flow cytometric determination of aminopeptidase and cathepsin D activities in living cells. Analytical Cellular Pathology 6(3): 257

Maiden, M.F.J.; Tanner, A.; Macuch, P.J. 1991: Fluorogenic substrate tests for the rapid identification of subgingival species. Journal of Dental Research 70(Special Issue): 318

Tzougraki, C.; Noula, C.; Geiger, R.; Kokotos, G. 1994: Fluorogenic substrates containing 7-amino-4-methyl-2-quinolinone for aminopeptidase M, chymotrypsin, elastase and trypsin, determination of enzyme activity. Liebigs Annalen der Chemie 1994(4): 365-368

Tssai, H.; Chen, H L. 1998: Fluorogenic substrates for assay of angiotensin converting enzyme. Official Gazette of the United States Patent and Trademark Office Patents 1208(1): 405

Tsien, R.Y.; Zlokarnik, G. 1998: Fluorogenic substrates for beta-lactamase and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1209(3): 2319

Weder, J.K.P.; Kaiser, K.P.ter 1995: Fluorogenic substrates for hydrolase detection following electrophoresis. Journal of Chromatography A 698(1-2): 181-201

Hagen, D.C.; Panchuk Voloshina, N.; Zhou, M.; Haugland, R.P.; Haugland, R.P. 1997: Fluorogenic substrates for the assay of gelatinases and collagenases. Molecular Biology of the Cell 8(Suppl ): 77A

Packard, B.Z.; Komoriya, A.; Brand, L. 1995: Fluorogenic substrates for the detection of proteases. Biophysical Journal 68(2 Part 2): A244

Zaidi, K.F.; Leaback, D.H. 1989: Fluorogenic techniques for monitoring metabolic changes in cells in culture. Analytica Chimica Acta 227(1): 273-286

Coward, J.K.; Mcguire, J.J.; Galivan, J. 1990: Fluoroglutamate containing folates and antifols probing the role of polyglutamylation in vitro. Curtius, H -C , S Ghisla And N Blau (Ed ) Chemistry And Biology Of Pteridines, 1989: Pteridines And Folic Acid Derivatives; Ninth International Symposium on Pteridines And Folic Acid Derivatives Chemical, Biological, And Clinical Aspects, Zurich, Switzerland, September 3-8, 1989 Xxxv+1340p Walter De Gruyter And Co : Berlin, West Germany; Hawthorne, New York, Usa Illus 1198-1202

Dosanjh, S.S.; Wiezorek, W.J.; Patel, J.; Iravani, M.M.; Kruk, Z.L. 1996: Fluorogold and dopaminergic function in the rat caudate putamen. British Journal of Pharmacology 117(Proceedings Suppl ): 312P

Vachon, M.P.; Staines, W.; Miliaressis, E. 1990: Fluorogold tracing after chemitrode injections of dorsal raphe afferents supporting brain stimulation reward. Society for Neuroscience Abstracts 16(1): 52

Emcorp (Usa) 1991: Fluorographic techniques and windows 30 based computer image analysis in enhanced autoradiography. FASEB Journal 5(6): A1789

Pennanen, N.; Lapinjoki, S.; Urtti, A.; Monkkonen, J. 1994: Fluoroimmunoassay of cytokines from murine macrophage-like RAW 264 cell line. Bone and Mineral 25(1): S35

Caruso, U.; Cohen, A.; De Carolis, F.; Lupino, S.; Lavagetto, A.; Romano, C. 1992: Fluoroimmunoassay of growth hormone Preliminary data. Acta Paediatrica Suppl 1992(383): 103

Wang W.K.; Ho L.T.; Chiang Y. 1990: Fluoroimmunoassay on metal surface by space resolved fluorometer. Clinical Chemistry 36(6): 1092

A.S.edi, S.; Dean, H.; Dent, W.; Stockl, E.; Cronin, C.M. 1994: Fluoroimmunoassay screening systematically overestimates serum 17-hydroxyprogesterone in premature infants. Pediatric Research 35(4 Part 2): 211A

Alihodzic, S.; Zinic, M.; Klaic, B.; Kiralj, R.; Kojic Prodic, B.; Herceg, M.; Cimerman, Z. 1993: Fluoroionophores with phenanthridinyl units. Tetrahedron Letters 34(51): 8345-8348

Kehne, H.; Willms, L.; Bauer, K.; Bieringer, H. 1997: Fluoromethylsulfonyl-substituted pyridylsulfonylureas as herbicides, process for their preparation, and their use. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 415

Reising, S.F.; Quinn, K.; Lindeman, S.; Doughman, J. 1993: Fluorometric ELISA method for rapid antiviral susceptibility testing of respiratory syncytial virus. Antiviral Research 20(Suppl 1): 153

Gartland, K.M.; Phillips, J.P.; Vitha, S.; Benes, K. 1995: Fluorometric GUS analysis for transformed plant material. Methods in Molecular Biology 44: 195-199

Jo, C.; Ahn, D.U. 1997: Fluorometric analysis of 2-thiobarbituric acid reactive substances in meat. Poultry Science 76(Suppl 1): 89

Rocco, R.M. 1991: Fluorometric analysis of acid phosphatase in meats for monitoring cooking temperatures. Journal of Food Protection 54(10): 814

Birnboim, H.C. 1990: Fluorometric analysis of DNA unwinding to study strand breaks and repair in mammalian cells. Methods in Enzymology 186: 550-555

Nagata, Y.; Yamamoto, Y.; Yamashita, S.; Niki, E. 1992: Fluorometric analysis of free fatty acid hydroperoxides and their alcohols, and its application to blood plasma. Yagi, K, Kondo, M, Niki, E, Yoshikawa, T International Congress Series; Oxygen radicals: 315-318

Smith, W.; Kelly, S.A.; Clark, O.E.IIi; Dejoseph, M.E.; Gross, C.L. 1998: Fluorometric analysis of intracellular changes induced by sulfur mustard in cultured human epidermal keratinocytes. Cytometry (Suppl 9): 65

Naganuma, M. 1994: Fluorometric analysis of liquid-crystalline to inverted hexagonal phase transition induced by diacylglycerol in liposomes. Hokkaido Journal of Medical Science 69(1): 65-71

Yaegashi, K.; Itoh, T.; Kosaka, T.; Kinoshita, T.; Fukushima, H.; Morimoto, T. 1994: Fluorometric analysis of oxygen supply and consumption in the rat mesentery. Japanese Journal of Physiology 44(Suppl 1): S95

Rothe, E.M.; Gross, H.J.; Raedsch, R.; Krause, J.M.; Brossmer, R.; Kommerell, B. 1993: Fluorometric assay differentiates sialyltransferases according to the acceptor specificity and histological stages of primary biliary cirrhosis. European Journal of Clinical Investigation 23(Suppl 1): A16

Penketh, P.G.; Shyam, K.; Sartorelli, A.C. 1997: Fluorometric assay for the determination of DNA-DNA cross-links utilizing Hoechst 33258 at neutral pH values. Analytical Biochemistry 252(1): 210-213

Gonzalo, P.; Sontag, B.; Guillot, D.; Reboud, J.P. 1995: Fluorometric assay of GTPase activity: application to the couple elongation factor eEF-2-ribosome. Analytical Biochemistry 225(1): 178-180

Calenoff, E.; Johnson, R.M.; Tsay Y G.; Scott, J. 1989: Fluorometric assay of allergic reactions us patent 4845027 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 470

Rao, A.M.; Hatcher, J.F.; Baskaya, M.K.; Dogan, A.; Vemuganti, R.; Dempsey, R.J. 1997: Fluorometric assay of nitrite and nitrate in brain tissue after head injury and ischemia. Society for Neuroscience Abstracts 23(1-2): 2193

Hwang, K.J.; Carlson, K.E.; Katzenellenbogen, J.A. 1991: Fluorometric assay of the estrogen receptor using tetrahydrochrysene derivatives as fluorescent ligands. Photochemistry and Photobiology 53(Suppl): 61S

Saha, S.K.; Moriya, M.; Ohinata, H.; Kuroshima, A. 1994: Fluorometric assay with hoechst 33258 of DNA in adipose tissues under various conditions. Japanese Journal of Physiology 44(Suppl 1): S281

Acker, J.P.; Mcgann, L.E. 1997: Fluorometric assessment of intracellular ice formation. Cryobiology 35(4): 363

Moore, K.H.; Dewitt, C.M. 1993: Fluorometric assessment of xenobiotic acyl-CoA formation. FASEB Journal 7(3-4): A170

Garner, D.L.; Thomas, C.A.; Marshall, C.E. 1996: Fluorometric assessments of acrosomal integrity and viability in cryopreserved bovine sperm. Molecular Biology of the Cell 7(Suppl ): 638A

Garner, D.L.; Thomas, C.A.; Dejarnette, J.M.; Marshall, C.E. 1997: Fluorometric assessments of cryopreservation effects on organelle function and viability in bovine sperm. Biology of Reproduction 56(Suppl 1): 98

Garner, D.L.; Thomas, C.A.; Jorg, H.W.; Dejarnette, J.M.; Marshall, C.E. 1997: Fluorometric assessments of mitochondrial function and viability in cryopreserved bovine sperm. Journal of Andrology 1997(Suppl ): P56

Gallagher, S.R. 1990: Fluorometric beta glucuronidase gus assay a laboratory exercise. Plant Physiology 93(1 Suppl): 109

Hirashima, Y.; Farooqui, A.A.; Horrocks, L.A. 1989: Fluorimetric coupled enzyme assay for lysoplasmalogenase activity in liver. Biochemical Journal 260(2): 605-608

Dai, F.; Zhang, H.; Malinowski, N.; Kelley, J.A.; Ford, H., J. 1998: Fluorometric determination of 2-fluoro-2,3-dideoxyadenosine-5-triphosphate, the active metabolite of a new anti-AIDS drug in human peripheral blood mononuclear cells by paired-ion, reversed phase chromatography. Abstracts of Papers American Chemical Society 216(1-3): ANYL 87

Resing, J.A.; Measures, C.I. 1994: Fluorometric determination of Al in seawater by flow injection analysis with in-line preconcentration. Analytical Chemistry 66(22): 4105-4111

Davis, C.E. 1996: Fluorometric determination of acid phosphatase in certain cooked poultry products Cooperative study. Poultry Science 75(Suppl 1): 53

Zhao Lanning, L.Z.; Luo Ying 1996: Fluorometric determination of cefalexin and cefradine. Zhongguo Kangshengsu Zazhi 21(4): 267-269, 276

Ingle, J.D.Jr; Louch, J. 1992: Fluorometric determination of chloroform in drinking water with a fiber optic chemical sensor. Abstracts of Papers American Chemical Society 203(1-3): ANYL14

Egawa, Y.; Hayashida, R.; Seki, T.; Anzai, J.-i. 2008: Fluorometric determination of heparin based on self-quenching of fluorescein-labeled protamine. Talanta 76(4): 736-741

Yucel, D.; Atik, T.N. 1994: Fluorometric determination of magnesium in mononuclear blood cells. Clinical Chemistry 40(6): 1097

Rodriguez, L.B.; Reglero, A.; Martinez Blanco, H.; Luengo, J.M. 1991: Fluorometric determination of phenylacetyl coenzyme a ligase from pseudomonas putida a very sensitive assay for a newly described enzyme. Biochimica et Biophysica Acta 1073(2): 432-433

Tabata, M.; Kaneko, K.; Murakami, Y.; Hisaeda, Y.; Mimura, H. 1994: Fluorometric determination of trace amounts of fluoride ion using an expanded porphyrin. Microchemical Journal 49(2-3): 136-144

Scott, J.R.; Leung, S.; Najmabadi, S.; Rodriguez, G.; Gautman Basak, M. 1991: Fluorometric elisa assay to determine igg subclasses. FASEB Journal 5(5): A1374

Harris, N.; Vigo Pelfrey, C. 1991: Fluorometric elisa to measure antinuclear antibodies. FASEB Journal 5(4): A643

Kapsner K.; St Cyr M.; Smith D. 1990: Fluorometric enzyme immunoassay for the determination of cortisol for use on the kallestad immunoassay analyzer. Clinical Chemistry 36(6): 1162

Oraivej, N.Y.; Tsalta, C.; Mccarthy, M. 1990: Fluorometric enzyme immunoassay for the determination of hcg for the kallestad immunoassay analyzer. Clinical Chemistry 36(6): 1159

Fitzgerald, D.; Hemker, S.; Strand, G.; Richter, D.; Twumasi, D.; Wegfahrt, P. 1990: Fluorometric enzyme immunoassay for the measurement of free t4 ft4 qualified for the kallestad immunoassay analyzer. Clinical Chemistry 36(6): 1148

Neelkantan, N.V.; Weston, S.; Lau, H.P. 1989: Fluorometric enzyme immunoassay for the measurement of free thyroxine using magnisep chromium dioxide particles. Clinical Chemistry 35(6): 1202

Fitzgerald, D.; Richter, D.; Richards, J.; Hemker, S.; Jawad, J.; Wegfahrt, P. 1989: Fluorometric enzyme immunoassay for the measurement of total thyroxine t4 using a reagent delivery module rdm. Clinical Chemistry 35(6): 1140

Zoha, S.J.; Neelkantan, N.V.; Lau, H.P.; Masulli, I.S.; Spaven, F.F.; Tuhy, P.M.; Farmer, M.G. 1989: Fluorometric enzyme immunoassay for the measurement of total triiodothyronine using magnisep chromium dioxide particles. Clinical Chemistry 35(6): 1202

Thomas, C.A.; Garner, D.L.; Gravance, C.G. 1998: Fluorometric examination of the effect of glycerol on bovine sperm organelles. Journal of Andrology (Suppl ): 53

Ezaki, T.; Hashimoto, Y.; Yamamoto, H.; Yabuuchi, E. 1989: Fluorometric hybridization in microdilution wells for the rapid identification of legionellae and other gram negative nonfermenting rods. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 456

Takanashi, T.; Ogura, Y.; Honda, Y. 1994: Fluorometric image analysis of intracellular oxidative products in cultured retinal pigment epithelium. IOVS Investigative Ophthalmology and Visual Science 35(4): 1767

Tervo, T.; Virtanen, T.; Honkanen, N.; Harkonen, M. 1992: Fluorometric method for tear fluid proteolytic enzymes. Experimental Eye Research 55(Suppl 1): S110

Liang F Q.; Huang R H. 1990: Fluorometric method for the determination of serotonin uptake into platelets and its thermodynamics. Zhongguo Yaolixue Yu Dulixue Zazhi 4(1): 77-78

Ogura, M.; Mitsuhashi, M. 1995: Fluorometric method for the measurement of nuclease activity on plastic plates. Biotechniques 18(2): 231-233

Sonavaria, V.J.; Williams, D.; Jambhekar, S. 1993: Fluorometric method of analysis for camptothecin using reversed phase high performance liquid chromatography. Pharmaceutical Research (New York) 10(10 Suppl): S55

Balashov, Y.G. 1990: Fluorometric micromethod for determining corticosteroids comparison with other methods. Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova 76(2): 280-283

Okamoto, T.; Mitsuhashi, M.; Kikkawa, Y. 1994: Fluorometric nuclear run-on assay with oligonucleotide probe immobilized on plastic plates. Analytical Biochemistry 221(1): 202-204

Schaeffer, W.I.; Simkins, S.; Wilson, J.; Melamede, R. 1992: Fluorometric quantitation of broth cultured mycoplasmas using alkaline ethidium bromide. Abstracts of the General Meeting of the American Society for Microbiology 92: 163

Schaeffer, W.I.; Melamede, R. 1997: Fluorometric quantitation of mycoplasmas. Official Gazette of the United States Patent and Trademark Office Patents 1195(3): 1908

Serrano, E.E.; Corvalan, V.; Young, S.H. 1991: Fluorometric studies of intracellular ph changes in guard cells. Plant Physiology 96(1 Suppl): 69

Omata, Y.; Friedman, F.K. 1990: Fluorometric studies on the active site conformation of cytochrome p 450. Biophysical Journal 57(2 Part 2): 230A

Norris, A.W.; Li, E. 1998: Fluorometric titration of the CRABPs. Methods in Molecular Biology 89: 123-139

Galbán, J.; de Marcos, S.; Castillo, J.R. 1993: Fluorometric-enzymatic lactate determination based on enzyme cytochrome b2 fluorescence. Analytical Chemistry 65(21): 3076-3080

Anderson,D.M.; Rayson,G.D. 2008: Fluorometry - an evolving methodology for range animal ecologists. Multifunctional Grasslands In A Changing World, Volume 1: Xxi International Grassland Congress And Viii International Rangeland Congress, Hohhot, China, 29 E 5 Y: 2

Studts, P.K.; Studts, D.J.; Huth, J.A. 1995: Fluorometry and fluorescence polarization. Haven, M C, Tetrault, G A, Schenken, J R Laboratory instrumentation, Fourth edition: 135-156

Teesalu, P.; Airaksinen, P.J.; Tuulonen, A.; Silk, S.; Nieminen, H.; Alanko, H. 1995: Fluorometry of the crystalline lens in correcting glue-on-yellow perimetry results for lens yellowing. IOVS Investigative Ophthalmology and Visual Science 36(4): S336

Bhat, M.; Prendergast, J.; Rojanasakul, Y.; Weber, S.; Castranova, V.; Ma, J.K.H. 1993: Fluoromicroscopic evaluation of taurine as an inhibitor for intracellular oxidation caused by bleomycin. Pharmaceutical Research (New York) 10(10 Suppl): S199

Bhat, M.; Rojanasakul, Y.; Weber, S.L.; Ma, J.Y.; Castranova, V.; Banks, D.E.; Ma, J.K. 1994: Fluoromicroscopic studies of bleomycin-induced intracellular oxidation in alveolar macrophages and its inhibition by taurine. Environmental Health Perspectives 102(Suppl 10): 91-96

Liu, R.S.; Yeh, S.H.; Chu, L.S.; Chang, C.P.; Wang, J.K.; Wu, L.C.; Chou, K.L.; Chang, C.W.; Lin, H.M.; Lee, L.S. 1995: Fluoromisonidazole PET scan in meningioma. Journal of Nuclear Medicine 36(5 Suppl): 222P

Haky, J.E.; Mannschrek, T.M. 1994: Fluorooctyl and fluorobutyl bonded alumina stationary phases for high performance liquid chromatography. Abstracts of Papers American Chemical Society 207(1-2): ANYL 5

Allmendinger, T.; Felder, E.; Hugnerbuehler, E. 1991: Fluoroolefin dipeptide isosteres. Welch, J T (Ed ) Acs (American Chemical Society) Symposium Series, Vol 456 Selective Fluorination in Organic And Bioorganic Chemistry; 199th National Meeting, Boston, Massachusetts, Usa, April 22-27, 1990 Viii+215p American Chemical Society: Washington, D C , Usa Illus 186-195

Allmendinger, T.; Furet, P.; Hungerbuehler, E. 1990: Fluoroolefin dipeptide isosteres 1 the synthesis of gly psi cf=chgly and racemic phe psi cf=ch gly. Tetrahedron Letters 31(50): 7297-7300

Allmendinger, T.; Felder, E.; Hungerbuehler, E. 1990: Fluoroolefin dipeptide isosteres ii enantioselective synthesis of both antipodes of the phenylalanine glycine dipeptide mimic. Tetrahedron Letters 31(50): 7301-7304

Boros, Livia G.; De Corte, Bart; Gimi, Rayomand H.; Welch, John T.; Wu, Yang; Handschumacher, Robert E. 1994: Fluoroolefin peptide isosteres Tools for controlling peptide conformations. Tetrahedron Letters 35(33): 6033-6036

Edmondson, S.D.; Wei, L.; Xu, J.; Shang, J.; Xu, S.; Pang, J.; Chaudhary, A.; Dean, D.C.; He, H.; Leiting, B.; Lyons, K.A.; Patel, R.A.; Patel, S.B.; Scapin, G.; Wu, J.K.; Beconi, M.G.; Thornberry, N.A.; Weber, A.E. 2008: Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors. Bioorganic and Medicinal Chemistry Letters 18(7): 2409-2413

Lafon, L. 1989: Fluorophenacylamine derivatives and application thereof in therapeutics us patent 4835315 may 30 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(5): 3357

Rogers, R.B.; Clifford, B. 1989: Fluorophenoxyphenoxypropionates and derivatives thereof us patent 4808750 february 28 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(4): 2236

Smith, T.M.; Stroebel, G.G.; Mcphersoni, J.C.I.; Chuang, A.H.; Mcpherson, J.C.Jr 1996: Fluorophore labeled poloxamers protect red blood cells. Abstracts of Papers American Chemical Society 211(1-2): MEDI 136

Jackson, P. 1993: Fluorophore-assisted carbohydrate electrophoresis: a new technology for the analysis of glycans. Biochemical Society Transactions 21(1): 121-125

Hu, G.F. 1995: Fluorophore-assisted carbohydrate electrophoresis technology and applications. Journal of Chromatography. a 705(1): 89-103

Masada, R.I.; Starr, C.M. 1993: Fluorophore-assisted-carbohydrate-electrophoresis sequence analysis of complex oligosaccharides. FASEB Journal 7(7): A1242

Pou, S.; Wu, S.Y.; Lederer, W.J.; Rosen, G.M. 1992: Fluorophore-containing nitroxide as a potential probe for the detection of free radicals in cells with fluorescence methodology. Yagi, K, Kondo, M, Niki, E, Yoshikawa, T International Congress Series; Oxygen radicals: 179-182

Tsien, R.Y.; Waggoner, A. 1995: Fluorophores for confocal microscopy Photophysics and photochemistry. Pawley, J B Handbook of biological confocal microscopy, Second edition 267-279

Takahashi, J.; Ishiko, S.; Yoshida, A.; Kitaya, N.; Abiko, T.; Mori, F.; Takeda, M.; Saito, K.; Ishimoto, B. 1996: Fluorophotometer fitted with a small animal adapter. IOVS Investigative Ophthalmology and Visual Science 37(3): S613

Verhoeven, M.H.; Khalil, H.A.; Van Best, J.A. 1989: Fluorophotometric determination of the basal tear production. International Ophthalmology 13(Suppl): 466

Borsje, R.A.; Vrensen, G.F.J.M.; Van Best, J.A.; Oosterhuis, J.A. 1989: Fluorophotometric determination of the blood retinal barrier after exposure to white light. International Ophthalmology 13(Suppl): 437

Borsje, R.A.; Vrensen, G.F.J.M.; Van Best, J.A.; Oosterhuis, J.A. 1989: Fluorophotometric determination of the function of the blood retina barrier after exposure of the rabbit eye to white light. International Ophthalmology 13(Suppl): 478-479

Khalil H.A.; Van Best J.A.; De Keizer R.J.W. 1989: Fluorophotometric determination of the permeability of the cornea in graves ophthalmopathy. International Ophthalmology 13(Suppl): 472

Boot, J.P.; Van Best, J.A.; Stolwijk, T.R.; Sterk, C.C.; Oosterhuis, J.A. 1989: Fluorophotometric determination of the permeability of the corneal epithelium after penetrating keratoplasty. International Ophthalmology 13(Suppl): 449

Hayashi, M.; Yablonski, M.E. 1990: Fluorophotometric determination of uveoscleral outflow j u and trabecular outflow facility c t r verified by invasive methods. IOVS Investigative Ophthalmology and Visual Science 31(4): 184

Taguchi, H.; Ogura, Y.; Takanashi, T.; Hashizoe, M.; Honda, Y. 1997: Fluorophotometric evaluation of intravitreal peroxides in endotoxin-induced uveitis. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S190

Yamada, M.; Kawai, M.; Hata, Y.; Mochizuki, H.; Mashima, Y. 1997: Fluorophotometric measurement of human tear buffering action in vivo. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S150

Nakajima, H.; Haruhata, Y.; Komatsu, Y.; Yamada, M.; Nii, S.; Mashima, Y. 1998: Fluorophotometric measurement of pH of human corneal epithelium in vivo. IOVS Investigative Ophthalmology and Visual Science 39(4): S541

Komuro, A.; Yokoi, N.; Nishida, K.; Kinoshita, S. 1995: Fluorophotometric measurement of tear turnover in dry eye. IOVS Investigative Ophthalmology and Visual Science 36(4): S994

Shimizu, A.; Yokoi, N.; Hirase, K.; Nishida, K.; Kinoshita, S. 1994: Fluorophotometric measurement of tear volume and turnover rate in normal and dry eyes. IOVS Investigative Ophthalmology and Visual Science 35(4): 1575

Hayashi, M.; Yablonski, M.E.; Toris, C.B. 1992: Fluorophotometric measurement of uveoscleral outflow. Experimental Eye Research 55(Suppl 1): S213

Brubaker, R.F. 1989: Fluorophotometric studies of prostaglandin effects on the human eye: the lack of association of reduced intraocular pressure with altered flow or barrier function. Progress in Clinical and Biological Research 312: 477-481

Ogino, N.; Kitagawa, K.; Ogura, Y. 1991: Fluorophotometric studies on nuclear cataracts after vitrectomy. IOVS Investigative Ophthalmology and Visual Science 32(4): 798

Wang, Y L.; Zhan, G.L.; Toris, C.B.; Yablonski, M.E. 1995: Fluorophotometric study of acetazolamide inhibition of fluid transport across cat corneal endothelium in vivo. IOVS Investigative Ophthalmology and Visual Science 36(4): S299

Tsuboi, S. 1990: Fluorophotometry 3 iii vitreous fluorophotometry. Folia Ophthalmologica Japonica 41(8): 1465-1466

Tsuboi, S. 1990: Fluorophotometry ii. Folia Ophthalmologica Japonica 41(7): 1289-1290

Labetoulle, M.; Baglivo, E.; Offret, H.; Ducot, B.; Offret, M.; Bloch Michel, E. 1996: Fluorophotometry in Fuchs heterochromic cyclitis. IOVS Investigative Ophthalmology and Visual Science 37(3): S1037

Wolosin, J.M.; Chen, M.; Gordon, R.; Stegman, Z.; Butler, G. 1992: Fluorophotometry of bicarbonate and ion transport in the isolated, native pigmented and nonpigmented layers of the rabbit ciliary body epithelium. Experimental Eye Research 55(Suppl 1): S95

Masur, S.K.; Michelson, K. 1992: Fluorophotometry of cytoskeletal function in corneal keratocytes. Experimental Eye Research 55(Suppl 1): S184

Koyama, M.; Iwata, M.; Kurihara, K.; Sezaki, M. 1989: Fluorophthalimides and agricultural and horticultural fungicides containing them us patent 4839378 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1260

Zimmerman, T.S.; Fulcher, C.A. 1989: Fluoroplastic immunoaffinity columns for purification of blood proteins us patent 4831118 may 16 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(3)

Schell, B.A.; Orem, M.W.; Wang, Y. 1998: Fluoropolyether containing aqueous coating compositions for an imaging element. Official Gazette of the United States Patent and Trademark Office Patents 1215(3): 2967

Bultman, J.D.; Griffith, J.R. 1994: Fluoropolymer and silicone fouling-release coatings. Thompson, M -F, Nagabhushanam, R, Sarojini, R, Fingerman, M Recent developments in biofouling control 383-389

Desimone, J.M. 1998: Fluoropolymer synthesis and processing using carbon dioxide. Abstracts of Papers American Chemical Society 215(1-2): ENVR 27

Danielson, N.D.; Beaver, L.G.; Wangsa, J. 1991: Fluoropolymers and fluorocarbon bonded phases as column packings for liquid chromatography. Journal of Chromatography 544(1-2): 187-200

Churchley, D.; Rees, G.D.; Barbu, E.; Nevell, T.G.; Tsibouklis, J. 2008: Fluoropolymers as low-surface-energy tooth coatings for oral care. International Journal of Pharmaceutics 352(1-2): 44-49

Li, Z.; Lang, L.; Ma, Y.; Kiesewetter, D., O. 2008: Fluoropropyisulfonyl chloride a new reagent for radiolabeling primary and secondary amines for PET imaging. Journal of Labelled Compounds and Radiopharmaceuticals 51(1-2): 23-27

Makino, K.; Suzuki, H.; Nagaoka, T.; Niki, T.; Kusuoka, Y.; Hamada, T.; Nawamaki, T.; Watanabe, S.; Ito, Y.; Sudo, K. 1998: Fluoropropylthiazoline derivatives and herbicides. Official Gazette of the United States Patent and Trademark Office Patents 121(2): 1683

Mancini, W.R.; Stetson, P.L.; Lawrence, T.S.; Wagner, J.G.; Greenberg, H.S.; Ensminger, W.D. 1990: Fluoropyrimidine modulation of brdurd incorporation into dna in human glioma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 31: 405

Mader, R.M.; Steger, G.G.; Sieder, A.E.; Rizovski, B.; Hamilton, G.; Roth, E.; Jakesz, R.; Rainer, H. 1992: Fluoropyrimidine resistance. European Journal of Clinical Investigation 22(4 Part 2): A37

Yokota, T.; Haramura, M.; Okamachi, A.; Makino, T. 1998: Fluoroquinoline derivative. Official Gazette of the United States Patent and Trademark Office Patents 1212(1): 648

Baba, M.; Okamoto, M.; Kawamura, M.; Makino, M.; Kimura, Y.; Ikeuchi, T.; Tetsuka, T.; Okamoto, T. 1998: Fluoroquinoline derivatives as potent inhibitors of HIV-1 replication and cytokine production. Antiviral Research 37(3): A56

Lavoie, E.J.; Defauw, J.; Fealy, M.; Mcqueen, C.A. 1989: Fluoroquinoline derivatives evaluation of genotoxic activity. Proceedings of the American Association for Cancer Research Annual Meeting 30: 140

Gootz, T.D.; Brighty, K.E. 1996: Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects. Medicinal Research Reviews 16(5): 433-486

Nakano, M.; Ishihara, S.; Deguchi, T.; Kuriyama, M.; Kawada, Y. 1997: Fluoroquinolone associated bladder stone. Journal of Urology 157(3): 946

Montero, M.T.; Hernandez Borrell, J.; Nag, K.; Keough, K.M.W. 1994: Fluoroquinolone distribution in a phospholipid environment studied by spectrofluorimetry. Analytica Chimica Acta 290(1-2): 58-64

Alvarez, A.I.; Pérez, M.; Prieto, J.G.; Molina, A.J.; Real, R.; Merino, G. 2008: Fluoroquinolone efflux mediated by ABC transporters. Journal of Pharmaceutical Sciences 97(9): 3483-3493

Loeuille, D.; Gillet, P.; Netter, P. 1996: Fluoroquinolone induced arthralgia and magnetic resonance imaging. Journal of Rheumatology 23(7): 1313-1314

Wanogho, E.; Burke, M.D. 1993: Fluoroquinolone inhibition of cytochrome P450. British Journal of Clinical Pharmacology 36(2): 168P

Ferguson, J. 1995: Fluoroquinolone photosensitization A review of clinical and laboratory studies. Photochemistry and Photobiology 62(6): 954-958

Jones, R.N. 1992: Fluoroquinolone resistance. An evolving national problem or just a problem for some physicians?. Diagnostic Microbiology and Infectious Disease 15(2): 177-179

Spigaglia, P.; Barbanti, F.; Mastrantonio, P.; Brazier, J.S.; Barbut, F.éd.ér.; Delmée, M.; Kuijper, E.; R Poxton, I.; On Behalf Of The European Study Group On Esgcd 2008: Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. Journal of Medical Microbiology 57(Part 6): 784-789

Knapp, J.S.; Fox, K.K.; Trees, D.L.; Whittington, W.L. 1997: Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerging Infectious Diseases 3(1): 33-39

Ross, J.D. 1998: Fluoroquinolone resistance in gonorrhoea: how, where and so what. International Journal of Std and Aids 9(6): 318-322

Bednova, V.N.; Bakalova, L.A. 1993: Fluoroquinolone therapy of urogenital infections using tarivid, ciprobay, and abactal. Vestnik Dermatologii i Venerologii 1993(3): 77

Gillet, P.; Blum, A.; Pierfitte, C.; Pourel, J.; Kessler, M.; Netter, P.; Royer, R.J.; Gaucher, A. 1993: Fluoroquinolone-associated Achilles tendinitis MRI findings. Arthritis and Rheumatism 36(9 Suppl): S163

Niesel, T.; Breul, J.; Kamereck, K.; Wagner, H.; Hartung, R.; Lehn, N. 1996: Fluoroquinolone-resistant E coli An increasing problem in treatment of urogenital infections?. Journal of Urology 155(5 Suppl): 676A

Winquist, A.; Ristow, T.; Postelnick, M.; Oliphant, C.; Engman, D.; Peterson, L. 1995: Fluoroquinolone-resistant Pseudomonas aeruginosa is not related to spread of a drug-resistant clone. Abstracts of the General Meeting of the American Society for Microbiology 95: 161

Donck, J.B.; Segaert, M.F.; Vanrenterghem, Y.F. 1994: Fluoroquinolones and Achilles tendinopathy in renal transplant recipients. Transplantation 58(6): 736-737

Norrby, S.R.; Wiström, J. 1992: Fluoroquinolones and bacterial enteric infections. Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 277(3): 273-275

Moati, L.; Bressolle, F.; Galtier, M.; Blayac, J.P. 1995: Fluoroquinolones and psychiatric events. Therapie (Paris) 1995(Suppl ): 189

Marti, H.P.; Stoller, R.; Frey, F.J. 1998: Fluoroquinolones as a cause of tendon disorders in patients with renal failure/renal transplants. British Journal of Rheumatology 37(3): 343-344

Rieutord, A.; Vazquez, L.; Soursac, M.; Prognon, P.; Blais, J.; Bourget, P.; Mahuzier, G. 1994: Fluoroquinolones as sensitizers of lanthanide fluorescence Application to the liquid chromatographic determination of ciprofloxacin using terbium. Analytica Chimica Acta 290(1-2): 215-225

Stevens, D.; Samples, J.R. 1994: Fluoroquinolones for the treatment of microbial infections. Journal of Toxicology Cutaneous and Ocular Toxicology 13(4): 275-277

Navashin, S.M.; Navashin, P.S. 1996: Fluoroquinolones in modern antibacterial therapy Future trends. Antibiotiki i Khimioterapiya 41(9): 4-10

Beloborodova, N.V.; Padeiskaya, E.N.; Biryukov, A.V. 1996: Fluoroquinolones in pediatrics - pro et contra. Pediatriya (Moscow) 1996(2): 76-84

LeBel, M. 1991: Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 10(4): 316-324

Padeiskaya, E.N.; Mnatsakanyan, V.E. 1993: Fluoroquinolones in the treatment of infectious caused by Pseudomonas aeruginosa A literature review. Khimiko-Farmatsevticheskii Zhurnal 27(6): 19-24

Zavala Trujillo, I.; Quiroz, C.; Gutierrez, M.A.; Arias, J.; Renteria, M. 1991: Fluoroquinolones in the treatment of typhoid fever and the carrier state. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 10(4): 334-341

Naber, K.G. 1996: Fluoroquinolones in urinary tract infections. Proper and improper use. Drugs 52(Suppl 2): 27-33

Underner, M.; Grignon, B.; Roblot, F.; Meurice, J.C.; Patte, F. 1989: Fluoroquinolones: pharmacology, antibacterial spectrum and indications in pneumology. Revue de Pneumologie Clinique 45(1): 14-22

Rossetti, S.B.; Malbran, E.; D'allesandro, L.; Malbran, J. 1995: Fluoroquinolones resistance among ocular bacteria. IOVS Investigative Ophthalmology and Visual Science 36(4): S153

Hayem, G.; Dormarle, O.; Khan, M.F.; Pocidalo, J.J. 1994: Fluoroquinolones stimulate the in vitro production of hydrogen peroxide, but not nitric oxide, by immature rabbit articular chondrocytes. Arthritis and Rheumatism 37(9 Suppl): S343

Rekhi, G.S.; Anand, K.J.S. 1991: Fluoroquinolones theophylline interaction. Canadian Journal of Hospital Pharmacy 44(6): 302-303

Karamanis, E.M.; Matthaiou, D.K.; Moraitis, L.I.; Falagas, M.E. 2008: Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine 33(10): E297-E304

Leray, H.; Borderie, P.; Mourad, G.; Canaud, B.; Mion, C. 1993: Fluoroquinolones, a risk factor for tendon rupture in older renal transplant recipients. Nephrology Dialysis Transplantation 8(9): 1043

Sano, H.; Adachi, R. 1997: Fluoroscopic apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3533-3534

Bevard, B.; Peterson, J.; Maxwell, S.; Anderson, W.; Pabst, R. 1996: Fluoroscopic assessment of meniscal movement in prosthetic knees. Journal of Investigative Medicine 44(1): 138A

Whitlock, W.L.; Teklinski, A.H.; Becker, G.L.; Weaver, S. 1990: Fluoroscopic assessment of unilateral diaphragm paralysis with a flow resistor. Chest 98(2 Suppl): 25S

Kirks, D.R. 1992: Fluoroscopic catheter removal of blunt esophageal foreign bodies. a pediatric radiologist's perspective. Pediatric Radiology 22(1): 64-65

Ward, W.G.; Bergfeld, J.A. 1993: Fluoroscopic demonstration of acute disruption of the fifth metatarsophalangeal sesamoid bones. American Journal of Sports Medicine 21(6): 895-897

Rubio, J.M.; Farre, J.; Tarin, N.; Castro Dorticos, J.; Cabrera, J.A. 1998: Fluoroscopic dimensions of the Triangle of Koch and feasibility of radiofrequency ablation of the slow nodal pathway. Journal of the American College of Cardiology 31(2 Suppl A): 473A

Rubio, J.M.; Farre, J.; Castro Dorticos, J.; Tarin, N.; Ayala, R.; Balaguer, J.; Madeira, J. 1998: Fluoroscopic dimensions of the triangle of Koch and feasibility of radiofrequency catheter ablation of the slow nodal pathway. European Heart Journal 19(ABST Suppl ): 235

Kennedy, R.S.; Renner, J.B.; Guilford, W.B.; Haswell, J.; Slegal, G.P. 1990: Fluoroscopic directed bone biopsy the importance of combined histopathology and cytologic evaluation. Laboratory Investigation 62(1): 51A

Smith, C.; Brubaker, L.; Saclarides, T.J. 1996: Fluoroscopic evaluation of the pelvic floor. Brubaker, L T, Saclarides, T J The female pelvic floor: Disorders of function and support: 81-88

Montorsi, P.; Arena, V.; Muratori, M.; Lavarra, F.; Cavoretto, D.; Repossini, A.; Guazzi, M.D. 1995: Fluoroscopic functional evaluation of bileaflet prosthetic heart valves Effects of different intraoperative valve orientations. European Heart Journal 16(ABSTR Suppl ): 356

Marciniak, B.; Fayoux, P.; Hébrard, A.; Engelhardt, T.; Weinachter, C.; Horber, R.K. 2008: Fluoroscopic guidance of Arndt endobronchial blocker placement for single-lung ventilation in small children. Acta Anaesthesiologica Scandinavica 52(7): 1003-1005

Kau, E.L.; Sigman, H.C.; Prasad, U.R.; Katz, P.G.; Szucs, R.A.; Averch, T.D. 1998: Fluoroscopic image interpretation A comparison between film and computer file. Journal of Endourology 12(Suppl 1): S156

Yassa, F.F.; Abdel Malek, A.A.; Bloomer, J.J. 1996: Fluoroscopic imager with frame-filling apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1183(3): 1730

Dash, H.H.; Bithal, P.K.; Muley, S.; Mishra, N.K.; Saini, S.S.; Tandon, P.N. 1989: Fluoroscopic imaging for monitoring tension pneumocephalus. Anesthesiology 71(3A): A1133

Thurley, P.D.; Hopper, M.A.; Jobling, J.C.; Teahon, K. 2008: Fluoroscopic insertion of post-pyloric feeding tubes: success rates and complications. Clinical Radiology 63(5): 543-548

Jakobs, R.; Adamek, H.E.; Maier, M.; Benz, C.; Kromer, M.; Riemann, J.F. 1996: Fluoroscopic-guided laser lithotripsy vs extracorporeal shock-wave lithotripsy for retained bile-duct stones A prospective, randomized study. Gastroenterology 110(4 Suppl): A458

McLoughlin, R.F.; O'Connor, G.; Dowsett, J.; Fitzgerald, M.X.; Gibney, R.G. 1994: Fluoroscopically guided percutaneous gastrostomy in patients with cystic fibrosis. Thorax 49(5): 519-520

Soble, J.J.; Nakada, S.Y.; Mcdougall, E.M.; Clayman, R.V. 1994: Fluoroscopically guided ureteral stent placement. Journal of Endourology 8(Suppl 1): S75

Verschakelen, J.A.; Deschepper, K.; Jiang, T.X.; Demedts, M. 1989: Fluoroscopically measured axial diaphragmatic displacement compared with respitrace derived rib cage and abdominal cross sectional area changes and calculated diaphragmatic volume displacement. American Review of Respiratory Disease 139(4 Part 2): A105

Dowd, P.E.; Culkin, D.J.; Mata, J.A.; Venable, D.D. 1993: Fluoroscopically monitored cystography for the diagnosis of spontaneous rupture of the bladder. Journal of Urology 149(4 Suppl): 486A

Daigle, J.B.; Demello, R.M.; Flight, B.W. 1995: Fluoroscopically viewable guidewire. Official Gazette of the United States Patent and Trademark Office Patents 1179(4): 2251

Abele, J.E. 1995: Fluoroscopically viewable multifilar calibrated guidewire and method for measuring occlusions with calibrated guidewires. Official Gazette of the United States Patent and Trademark Office Patents 1180(2): 731

Soble, J.J.; Nakada, S.Y.; Mcdougall, E.M.; Clayman, R.V. 1995: Fluoroscopically-guided co-axial ureteral stent placement. Journal of Urology 153(4 Suppl): 222A

Landsman, I.S.; Gronert, B.J.; Wiener, E.S.; Ford, H.R. 1994: Fluoroscopy as an aid to anesthetic management for bronchogenic cyst resection. Anesthesia and Analgesia 79(4): 803-805

Hofstetter, R.; Slomczykowski, M.; Bourquin, I.; Nolte, L.P. 1997: Fluoroscopy based surgical navigation Concept and clinical applications. Lemke, H J , Vannier, M W , Inamura, K International Congress Series; CAR '97 Computer assisted radiology and surgery 956-960

Azzouz, M.; Leff, D.; Molloy, P.; Kania, R.; Flinko, J.; Khatib, A.; Kosec, N.; Van Thiel, D.; Friedlander, L. 1997: Fluoroscopy guided percutaneous liver biopsy, an alternative approach to guided techniques. Gastroenterology 112(4 Suppl): A1217

Kenton, K.; Brubaker, L. 1996: Fluoroscopy is necessary to confirm visceral position in women with pelvic organ prolapse. Neurourology and Urodynamics 15(4): 354-355

Kaufman, B.A.; Moran, C.J.; Schlesinger, J. 1997: Fluoroscopy of programmable cerebrospinal fluid shunt valve settings. Technical illustration. Journal of Neurosurgery 86(4): 735

Jain, S.; Shah, N.; Bedford, R. 1990: Fluoroscopy or ct scan for celiac plexus block cpb. Anesthesiology 73(3A): 794

Mortensen, K.; Aydin, M.A.; Goldmann, B.; Deuse, T.; Willems, S.; Ventura, R. 2008: Fluoroscopy to assess late heart and lung perforation by a permanent ventricular pacemaker lead. a case complicated by isolated hemothorax. International Journal of Cardiology 128(1): 104-106

Payne, J.Thomas 1992: Fluoroscopy trends high level and special procedures. Poznanski, A K Proceedings of the Annual Meeting of the National Council on Radiation Protection and Measurements; Radiation protection in medicine: 135-137

Bellamy, C.D.; Hagen, B.; Gunzenhaeuser, L.F. 1993: Fluoroscopy useful for epidural steroid injections. Regional Anesthesia 18(2 Suppl): 41

Zenoni S.; Bottoni F.; Vinciguerra P.; Sborgia M.; De Molfetta V. 1991: Fluorosilicone oil for the treatment of complicated retinal detachment. IOVS Investigative Ophthalmology and Visual Science 32(4): 882

Lewis, H.A.; Mohamed, U.; Chikte, E.; Butchart, A. 1992: Fluorosis and dental caries in schoolchildren from rural areas with about 9 and 1 ppm fluorine in the water supplies. Community Dentistry and Oral Epidemiology 20(1): 53-54

Disney, J.; Cutress, T.; Bohannan, H.; Graves, R.; Zack, D. 1992: Fluorosis experience of children enrolled in a caries risk study. Journal of Dental Research 71(Special Issue): 749

Katz, R.V.; Meskin, L.H. 1991: Fluorosis in bermuda north atlantic ocean children after 10 years of a school based fluoride supplement program. Journal of Dental Research 70(Special Issue): 358

Macicek,P.; Krook,L.P. 2008: Fluorosis in horses drinking artificially fluoridated water. Fluoride: 3, 177-183

Skobe, Z.; Heeley, J.; Kashket, S.; Dobeck, J.; Malatantis, G.; Hampe, C.; Mccrady, J.; Maravelis, L.; Stern, D.; Prostak, K. 1989: Fluorosis in maxillary vs mandibular rat incisors from two suppliers. Journal of Dental Research 68(Special Issue): 379

De Vernejoul, M.C. 1990: Fluorosis, osteopetrosis, and ectopic calcification. Current Opinion in Rheumatology 2(1): 44-46

Porcar, C.; Bronsoms, J.; Lopez-Bonet, E.; Valles, M. 1998: Fluorosis, osteomalacia and pseudohyperparathyroidism in a patient with renal failure. Nephron 79(2): 234-235

Koch, K. 1997: Fluorosugar derivatives of macrolides. Official Gazette of the United States Patent and Trademark Office Patents 1196(3): 1917

Maloo, J.C.; Radhakrishnan, K.; Thacker, A.K.; Mousa, M.E. 1990: Fluorotic radiculomyelopathy in a Libyan male. Clinical Neurology and Neurosurgery 92(1): 63-65

Fornasiero, A.; Ghiotto, C.; Daniele, O.; Biason, R.; Piacentini, P.; Fiorentino, M.V. 1994: Fluorouracil , leucovorin and mitoxantrone as salvage therapy in refractory disseminated breast cancer. Breast Cancer Research and Treatment 32(Suppl ): 37

Morittu, L.; Verusio, C.; Rosso, A.; Bordogna, G.; Aldrighetti, D.; Martinenghi, C.; Ceresoli, G.; Bolognesi, A. 1990: Fluorouracil and folinic acid in metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 659

Erlichman, C. 1990: Fluorouracil and leucovorin for metastatic colorectal cancer. Journal of ChemoTherapy 2 Suppl. 1: 38-40

Rosso, R.; Sobrero, A.; Nobile, M.T.; Tixi, L. 1991: Fluorouracil combined with folinic acid in advanced colorectal cancer. Journal of Surgical Oncology (Suppl 2): 184-185

Punt, C.J.; de Mulder, P.H.; Burghouts, J.T.; Wagener, D.J. 1992: Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer. Seminars in Oncology 19(2 Suppl 3: 208-210

Calabresi, F.; Di Lauro, L.; Marolla, P.; Curcio, C.G.; Paoletti, G.; Calabró, A.; Giannarelli, D.; Ballatore, P.; Foggi, C.M.; Di Palma, M. 1991: Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study. Seminars in Oncology 18(2 Suppl 4: 66-72

Brunetti, I.; Falcone, A.; Calabresi, P.; Goulette, F.; Darnowski, J.W. 1990: Fluorouracil enhances azidothymidine antineoplastic activity and incorporation into tissue nucleic acids. Proceedings of the American Association for Cancer Research Annual Meeting 31: 401

Preti, P.; Imparato, E.; Pavesi, L.; Della Cuna, G.R. 1990: Fluorouracil f plus mitomycin c m as second line therapy for drug refractory ovarian cancer. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 528

Darnowski, J.W.; Goulette, F.A. 1992: Fluorouracil increases azidothymidine cytotoxicity by altering dttp pools. Proceedings of the American Association for Cancer Research Annual Meeting 33: 421

Moreira, M.H., D.B.; Vaz, F. 1996: Fluorouracil induced immune hemolytic anemia. Vox Sanguinis 70(Suppl 2): 156

Fiorentino, M.V.; Brandes, A.; Fornasiero, A.; Pastorelli, D.; Daniele, O.; Soesan, M. 1991: Fluorouracil leucovorin and carboplatin in advanced breast cancer. Anti-Cancer Drug Design 6(4): 235

Darnowski, J.W.; Brunetti, I.; Posner, M.; Weitberg, A.; Falcone, A.; Goulette, F.; Corvese, D.; Calabresi, P. 1990: Fluorouracil plus azidothymidine cytotoxicity in vitro relationship to cellular thymidine kinase activity. Proceedings of the American Association for Cancer Research Annual Meeting 31: 398

Preiss, J. 1992: Fluorouracil plus interferon plus folinic acid in regional and systemic therapy in colorectal cancer. Seminars in Oncology 19(2 Suppl 3): 220-224

Singh, S.; Lin, D.; Brosseau, K.; Yu, N.Y.; Kaleta Michaels, S.; Brown, D.M. 1994: Fluorouracil therapeutic adhesive inhibits tumor growth in a mouse intraabdominal carcinomatosis model. Proceedings of the American Association for Cancer Research Annual Meeting 35: 414

Ajani, J.A.; Winter, K.A.; Gunderson, L.L.; Pedersen, J.; Benson, A.B.; Thomas, C.R.; Mayer, R.J.; Haddock, M.G.; Rich, T.A.; Willett, C. 2008: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16): 1914-1921

Tomasic, N.A.; Bennett, C.J.; Boyd, S.D.; Lieskovsky, G.; Keller, T.; Skinner, D.G. 1993: Fluorourodynamic and clinical evaluation after construction of a Kock ileal-urethral reservoir. Journal of Urology 149(4 Suppl): 326A

Curran, D.P. 1998: Fluorous synthesis: an alternative to organic synthesis and solid phase synthesis for the preparation of small organic molecules. Cancer Journal from Scientific American 4(Suppl 1): S73-S76

Sharma, D.S.; Rode, V.P. 1966: Fluorspar occurrence near Koteshwar in Barwaha Tehsil, Dhar forests, MP. Current Science 35(16): 411-412

Millar, D.B. 1993: Fluorstamp. Biotechniques 14(5): 764

Pento, J.T. 1992: Fluosol. Drugs of Today 28(6): 383-385

Ingram, D.A.; Forman, M.B.; Murray, J.J. 1992: Fluosol activates human neutrophils via phagocytosis a novel therapeutic approach to reduce myocardial reperfusion injury. Journal of the American College of Cardiology 19(3 Suppl A): 58A

Dowling, S.; Fischer, J.J.; Rockwell, S. 1992: Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study. Biomaterials Artificial Cells and Immobilization Biotechnology: Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology 20(2-4): 903-905

Spence, R.K.; Mccoy, S.; Costabile, J.; Norcross, E.D.; Pello, M.; Alexander, J.; Atabek, U.; Wisdom, C.; Camishion, R. 1992: Fluosol da 20 percent in treatment of severe anemia ongoing studies in 52 patients. Biomaterials Artificial Cells and Immobilization Biotechnology 20(2-4): 1069

Goldstick, T.K.; Ernest, J.T.; Deutsch, T.A.; Winchell, G.A. 1991: Fluosol da exchange transfusion increases tissue oxygen tension in hemodiluted cats breathing 100 percent oxygen. Biomaterials Artificial Cells and Immobilization Biotechnology 19(2): 386

Wade, E.L.; Eddy, L.J.; Green, D. 1994: Fluosol in sickle cell vaso-occlusive crisis. Clinical Research 42(3): 395A

Arora, R.R.; Sharma, R.; Sinha, A.K. 1993: Fluosol mediated inhibition of ADP induced platelet aggregation and prolongation of recalcification time in human plasma. Clinical Research 41(2): 119A

Garewal, H.; Skarin, A.; Kessler, J.; Smith, R.; Hedberg, J. 1989: Fluosol oxygen in combination with cyclophosphamide in advanced non small cell lung carcinoma nsclc phase i results. Proceedings of the American Association for Cancer Research Annual Meeting 30: 271

Vitola, J.V.; Ingram, D.A.; Holsinger, J.P.; Atkinson, J.B.; Forman, M.B.; Murray, J.J. 1995: Fluosol reduces myocardial reperfusion injury by prolonged suppression of neutrophils by its detergent component and not by enhancing O-2 delivery. Journal of the American College of Cardiology 1995(SPEC ISSUE): 103A

Akiyama, T.; Nakamura, K.T.; Takahashi, Y.; Naganawa, H.; Muraoka, Y.; Aoyagi, T.; Takeuchi, T. 1998: Fluostatins A and B, new inhibitors of dipeptidyl peptidase III, produced by Streptomyces sp. TA-3391. II. Structure determination. Journal of Antibiotics 51(6): 586-588

Vasil'ev, A.V.; Sivusangkar, S.; Margolina, A.A.; Lepilin, M.G.; Akchurin, R.S. 1997: Fluothane, enflurane, and nitrogen oxide Effects of myocardial metabolism in coronary patients. Anesteziologiya i Reanimatologiya 1997(6): 15-18

Stokes, P.E. 1993: Fluoxetine: a five-year review. Clinical Therapeutics 15(2): 216-243; Discussion 215

Harris, M.G.; Benfield, P. 1995: Fluoxetine. a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs and Aging 6(1): 64-84

Messiha, F.S. 1993: Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms. Neuroscience and Biobehavioral Reviews 17(4): 385-396

Chin, C.K.; Roe, C.J.; Thomas, G.W. 1996: Fluoxetine: a treatment option for severe symptomatic postural hypotension in a diabetic haemodialysis patient. Australian and New Zealand Journal of Medicine 26(5): 714

Preskom, S.; Shad, M.; Alderman, J.; Lane, R. 1998: Fluoxetine Age and dose dependent pharmacokinetics and CYP 2C19 inhibition. Clinical Pharmacology and Therapeutics 63(2): 166

Goldstein, D.J.; Roback, P.J. 1994: Fluoxetine Double-blind rechallenge of successful patients. International Journal of Obesity 18(Suppl 2): 61

Demedts, P.; Franck, F.; Wauters, A.; Neels, H. 1998: Fluoxetine: is the syndrome of inappropriate secretion of antidiuretic hormone in elderly patients associated with elevated serum levels?. Journal of Toxicology. Clinical Toxicology 36(1-2): 129-132

Scrimali, T.; Grimaldi, L.; Cultrera, G. 1990: Fluoxetine a new serotoninergic antidepressant employed in the therapy of the panic attacks. Neuroscience Letters Suppl (39): S198

Fuller, R.W.; Wong, D.T.; Robertson, D.W. 1991: Fluoxetine, a selective inhibitor of serotonin uptake. Medicinal Research Reviews 11(1): 17-34

Fuller, R.W.; Wong, D.T. 1989: Fluoxetine a serotonergic appetite suppressant drug. Drug Development Research 17(1): 1-16

Tacke, U. 1989: Fluoxetine: an alternative to the tricyclics in the treatment of major depression?. American Journal of the Medical Sciences 298(2): 126-129

Koch, S.; Galloway, M.P. 1994: Fluoxetine and -MDMA-induced dopamine release in vivo The role of endogenous serotonin. Society for Neuroscience Abstracts 20(1-2): 1558

Mijnster, M.J.; Van Haeften, T.; Voorn, P. 1996: Fluoxetine and DOI reduce mRNA levels of neuropeptides and glutamic acid decarboxylase in the striatum of the rat. Society for Neuroscience Abstracts 22(1-3): 409

Yaron, I.; Shirazi, I.; Judovich, R.; Yaron, M. 1998: Fluoxetine and amitriptyline inhibit nitric oxide, hyaluronic acid and prostaglandin E production in human synovial cells and synovial tissue cultures. Arthritis and Rheumatism 41(9 Suppl): S40

Wilcox, J.A. 1990: Fluoxetine and bulimia. Journal of Psychoactive Drugs 22(1): 81-82

Gobert, A.; Rivet, J.M.; Spedding, M.; Cistarelli, L.; Girardon, S.; Millan, M.J. 1996: Fluoxetine and duloxetine simultaneously release serotonin , dopamine and noradrenaline in the frontal cortex of freely-moving rats Way 100,635 selectively potentiates the induction of 5-HT release. Society for Neuroscience Abstracts 22(1-3): 943

Ahmad, S. 1991: Fluoxetine and glaucoma. Dicp: the Annals of PharmacoTherapy 25(4): 436

Wong, D.T.; Fuller, R.W.; Robertson, D.W. 1990: Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. Acta Pharmaceutica Nordica 2(3): 171-180

Hall, L.M.; Anderson, G.M.; Cohen, D.J. 1994: Fluoxetine and mouse brain norepinephrine turnover A preliminary study relevant to the mechanism of drug-induced akathisia. Society for Neuroscience Abstracts 20(1-2): 1277

Halman, M.; Goldbloom, D.S. 1990: Fluoxetine and neuroleptic malignant syndrome. Biological Psychiatry 28(6): 518-521

Fox, D.J.; Long, G.; Telepchak, M. 1992: Fluoxetine and norfluoxetine analysis using solid phase extraction and gc ms detection. Abstracts of Papers American Chemical Society 203(1-3): ENVR186

Lopez, C.; Lykissa, E.D.; Kammerer, R.C. 1989: Fluoxetine and norfluoxetine determination in serum by capillary gc ecd with solid phase extraction. Clinical Chemistry 35(6): 1169

Amitai, Y.; Kennedy, E.J.; Desandre, P.; Fawcett, J.; Frischer, H. 1992: Fluoxetine and norfluoxetine in red cells and plasma. Veterinary and Human Toxicology 34(4): 349

Vandel, S.; Bertschy, G.; Bouquet, S.; Bonin, B.; Vittouris, N. 1994: Fluoxetine and norfluoxetine plasma levels after treatment discontinuation in man. Therapie 49(2): 141-142

Caracci, G.; Decina, P. 1991: Fluoxetine and Prolonged Seizure. Convulsive Therapy 7(2): 145-147

Bakshi, R. 1996: Fluoxetine and restless legs syndrome. Journal of the Neurological Sciences 142(1-2): 151-152

Power, A.C.; Cowen, P.J. 1992: Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy. British Journal of Psychiatry: the Journal of Mental Science 161: 735-741

Burns, J.T.; Gryskevich, C.L.; Artman, S.A.; Hon, D.M.; Huffner, J.A.; Jones, B.R. 1992: Fluoxetine and the circadian rhythm of locomotion in the earthworm, Lumbricus terrestris. Journal of Interdisciplinary Cycle Research 23(3): 218-219

Reeve, H.L.; Archer, S.L.; Weir, E.K. 1998: Fluoxetine and venlafaxine cause K+ current inhibition but minimal membrane depolarization in rat pulmonary artery smooth muscle cells A contrast to dexfenfluramine. FASEB Journal 12(5): A989

Omar, S.J.; Robinson, D.; Davies, H.D.; Miller, T.P.; Tinklenberg, J.R. 1995: Fluoxetine and visual hallucinations in dementia. Biological Psychiatry 38(8): 556-558

Kinney-Parker, J.L.; Smith, D.; Ingle, S.F. 1989: Fluoxetine and weight: something lost and something gained?. Clinical Pharmacy 8(10): 727-733

Ruhrmann, S.; Kasper, S.; Hawellek, B.; Martinez, B.; Hoeflich, G.; Nickelsen, T.; Moeller, H.J. 1993: Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder. Pharmacopsychiatry 26(5): 193

Brymer, C.; Winograd, C. 1991: Fluoxetine associated weight loss in depressed elderly patients. Journal of the American Geriatrics Society 39(8): A3

Sabol, K.E.; Richards, J.B.; Seiden, L.S. 1991: Fluoxetine attenuates fenfluramine induced increases in extracellular serotonin in vivo. Society for Neuroscience Abstracts 17(1-2): 1181

Sills, T.L.; Fletcher, P.J. 1997: Fluoxetine attenuates morphine-induced locomotion and blocks morphine-induced sensitization. Society for Neuroscience Abstracts 23(1-2): 528

Harris, G.C.; Aston Jones, G. 1998: Fluoxetine attenuates symptoms of opiate withdrawal. Society for Neuroscience Abstracts 24(1-2): 1739

Frank, M.; Johnson, D.; Hendricks, S.; Wieseler, J. 1998: Fluoxetine augments natural killer cell activity in vitro Modulation by the 5-HT1alpha antagonist pindobind. FASEB Journal 12(5): A905

Wennemer, H.K.; Kornetsky, C. 1996: Fluoxetine blocks the expression but not the development of morphine-induced sensitization of oral stereotypy in the rat. Society for Neuroscience Abstracts 22(1-3): 173

Naranjo, C.A.; Bremner, K.E.; Poulos, C.X.; Lanctot, K.L. 1992: Fluoxetine decreases desire for alcohol. Clinical Pharmacology and Therapeutics 51(2): 168

Spreekmeester, E.; Mar, A.; Rochford, J. 1998: Fluoxetine decreases the sensitivity to the locomotor inhibitory effects of the alpha-2 receptor agonist, clonidine. Society for Neuroscience Abstracts 24(1-2): 1442

Sukoff, S.J.; Rosenzweig Lipson, S. 1998: Fluoxetine does not modify WAY 100635 5-HT1A antagonist behavioral effects in rats. Society for Neuroscience Abstracts 24(1-2): 1365

Norton, K.; Sanders, B.F.; Linarelli, L.G. 1996: Fluoxetine effects on appetite and behavior in Prader-Willi syndrome. Journal of Investigative Medicine 44(1): 187A

Goldberg, M.J.; Bergstrom, R.F.; Cerimele, B.J.; Thomasson, H.R.; Hatcher, B.L.; Simcox, E.A. 1997: Fluoxetine effects on pindolol pharmacokinetics. Clinical Pharmacology and Therapeutics 61(2): 178

Fuller, R.W. 1996: Fluoxetine effects on serotonin function and aggressive behavior. Annals of the new York Academy of Sciences 794: 90-97

Weintraub, M.; Singh, S.; Rubio, A. 1993: Fluoxetine effects on uric acid Failure to replicate previous observations. Clinical Pharmacology and Therapeutics 53(2): 220

Wise, S.D. 1989: Fluoxetine efficacy and safety in treatment of obese type 2 non insulin dependent diabetes. Diabetologia 32(7): 557A

Rosenthal, J.S.; Kaswan, M.J.; Hemlock, C.; Winston, A. 1991: Fluoxetine enhancement of heterocyclic antidepressants. Amsterdam, J D (Ed ) Advances in Neuropsychiatry And Psychopharmacology, Vol 2 Refractory Depression Xv+249p Raven Press: New York, New York, Usa Illus 105-108

Dupont, L.J.; Pype, J.L.; Demedts, M.G.; Verleden, G.M. 1996: Fluoxetine enhances the 5-HT-induced inhibition of the non-cholinergic contraction in guinea-pig airways in vitro. European Respiratory Journal Suppl 9(23): 133S-134S

Goldston, D.J.; Williams, M.L.; Pearson, D.K. 1991: Fluoxetine exposed pregnancies. Clinical Research 39(3): 768A

Naranjo, C.A.; Sellers, E.M.; Kadlec, K.E.; Woodley Remus, D.V.; Valencia, H.; Sanhueza, P.; Kennedy, G. 1989: Fluoxetine f differentially alters consummatory behaviors. Clinical Pharmacology and Therapeutics 45(2): 171

Shockley, R.A.; Stephens, R.L.Jr 1991: Fluoxetine f1 pretreatment potentiates intracisternal ic trh analogue stimulated gastric acid secretion in rats. Society for Neuroscience Abstracts 17(1-2): 1365

Schreiber, S.; Pick, C.G. 1995: Fluoxetine for blepharospasm: interaction of serotonin and dopamine. Journal of Nervous and Mental Disease 183(11): 719-721

Black, B.; Uhde, T.W.; Tancer, M.E. 1992: Fluoxetine for the treatment of social phobia. Journal of Clinical Psychopharmacology 12(4): 293-295

Koran, L.M.; Ringold, A.; Hewlett, W. 1992: Fluoxetine for trichotillomania: an open clinical trial. Psychopharmacology Bulletin 28(2): 145-149

Traugott, U.; Trejo, V. 1997: Fluoxetine greatly inhibits disease progression in chronic experimental allergic encephalomyelitis in SJL/J mice. Neurology 48(3 Suppl 2): A422

Wood, W.D.; Glen, A.; Blackburn, T.P.; Lee, J.A.; Sutiphong, J.A.; Kumar, C.; Carey, J.; Robinson, J. 1993: Fluoxetine has high affinity for the cloned rat and human 5-HT-1C receptor and the human 5-HT-2 receptor. British Journal of Pharmacology 110(Proceedings Suppl OCT ): 102P

Dixon, R.; Smith, D.A.; Polvino, W. 1998: Fluoxetine has no effects on the pharmacokinetics, pharmacodynamics or safety profile of zolmitriptan. Neurology 50(4 Suppl 4): A265

Nelson, C.J.; Jordan, W.P. 1995: Fluoxetine impairs acquisition of an avoidance response in rats. Society for Neuroscience Abstracts 21(1-3): 975

Seliger, G.M.; Herbert, J.; Hornstein, A.; Flax, J.; Schroeder, K.; Guarracini, M. 1990: Fluoxetine improves pseudobulbar affect. Neurology 40(4 Suppl 1): 327

Lindenmayer, J.P.; Vakharia, M.; Kanofsky, D. 1990: Fluoxetine in chronic schizophrenia. Journal of Clinical Psychopharmacology 10(1): 76

Goldstein, D.J.; Hamilton, S.H.; Masica, D.N.; Beasley, C.M.Jr 1995: Fluoxetine in depressed geriatric patients Effect on weight. Clinical Pharmacology and Therapeutics 57(2): 201

Levy, N.B.; Blumenfield, M.; Beasley, C.M.; Dubey, A.K.; Solomon, R.J.; Todd, R.; Goodman, A.; Bergstrom, R.R. 1996: Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. General Hospital Psychiatry 18(1): 8-13

Goldstein, D.J.; Rampey, A.H.; Potvin, J.H.; Fludzinski, L.A. 1992: Fluoxetine in obese patients with non insulin dependent diabetes mellitus. Clinical Research 40(2): 240A

Montastruc, J.L.; Senard, J.M.; Brefel, C.; Blin, O.; Brunelle, F.; Rascol, O. 1995: Fluoxetine in orthostatic hypotension A pilot study in Parkinsons disease. Therapie (Paris) 1995(Suppl ): 164

Klieser, E.; Lehmann, E.; Heinrich, K. 1993: Fluoxetine in patients with major depressive disorders An analysis of responders. Pharmacopsychiatry 26(5): 168

Fontaine, R.; Chouinard, G. 1989: Fluoxetine in the long term maintenance treatment of obsessive compulsive disorder. Psychiatric Annals 19(2): 88-91

Wheadon, D.E.; Wilson, M.G.; Rampey, A.H.; Thompson, V.L. 1991: Fluoxetine in the long term treatment of bulimia nervosa. Clinical Research 39(3): 769A

Costall, B.; Naylor, R.J. 1997: Fluoxetine in the presence of ritanserin enhances the potency of diazepam to disinhibit behaviour in the mouse light dark test. British Journal of Pharmacology 120(Proceedings Suppl ): 255P

Polson, R.; O'shea J.K.; Fleming, P.M. 1992: Fluoxetine in the treatment of illegal drug withdrawal. Human Psychopharmacology 7(3): 223-224

Eisen, A. 1990: Fluoxetine in the treatment of obsessive compulsive disorders. Human Psychopharmacology 5(1): 63

Bross, R.; Hoffer, L.J. 1994: Fluoxetine increases body temperature and resting energy expenditure in humans. FASEB Journal 8(4-5): A812

Potter Van Loon, B.J.; Radder, J.K.; Frolich, M.; Krans, H.M.J.; Meinders, A.E. 1990: Fluoxetine increases insulin action. Diabetologia 33(Suppl): A124

Pasini, A.; Spalletta, G.; Di Michele, F.; Furnari, C.; Fucci, P.; Ciani, N.; Romeo, E. 1995: Fluoxetine increases plasma levels of allopregnanolone in depressed patients. Society for Neuroscience Abstracts 21(1-3): 977

Rossby, P.; Perrin, C.; Burt, A.; Nalepa, I.; Spector, S.; Sulser, F. 1995: Fluoxetine increases steady-state levels of preproenkephalin mRNA in rat striatum and amygdala. Society for Neuroscience Abstracts 21(1-3): 1694

Mander, A.; McCausland, M.; Workman, B.; Flamer, H.; Christophidis, N. 1994: Fluoxetine induced dyskinesia. Australian and New Zealand Journal of Psychiatry 28(2): 328-330

Yells, D.; Prendergast, M.; Hendricks, S.; Nakamura, M.; And, D.F.; Rosa Milinar, E. 1992: Fluoxetine induced inhibition of male rat sexual behavior Possible role of the nucleus paragigantocellularis. Society for Neuroscience Abstracts 18(1-2): 537

Torres, G.; Horowitz, J.M.; Laflamme, N.; Rivest, S. 1997: Fluoxetine induces the transcription of genes encoding c-fos, CRF and its type 1 receptor in rat brain. Society for Neuroscience Abstracts 23(1-2): 991

Rieg, T.S.; Ahmed, I.; Lauterio, T.J.; Aravich, P.F. 1993: Fluoxetine induces thymus oxytocin abnormalities in activity-based anorexia. Annals of the new York Academy of Sciences 689: 465-468

Aravich, P.F.; Rieg, T.S.; Ahmed, I.; Downing, S.; Lauterio, T.J. 1991: Fluoxetine induces vasopressin abnormalities in activity based anorexia. Society for Neuroscience Abstracts 17(1-2): 1190

Spiller, H.A.; Morse, S.; Muir, C. 1990: Fluoxetine ingestion: a one year retrospective study. Veterinary and Human Toxicology 32(2): 153-155

Faynor, S.M.; Espina, V. 1989: Fluoxetine inhibition of imipramine metabolism. Clinical Chemistry 35(6): 1180

Cantor, J.M.; Binik, Y.; Pfaus, J.G. 1996: Fluoxetine inhibition of male rat sexual behavior Reversal by oxytocin. Society for Neuroscience Abstracts 22(1-3): 154

Shader, R.I.; Greenblatt, D.J.; von Moltke, L.L. 1994: Fluoxetine inhibition of phenytoin metabolism. Journal of Clinical Psychopharmacology 14(6): 375-376

Kazakoff, P.; Mcguire, T.; Giambattista, P.; Iversen, P. 1996: Fluoxetine inhibits apoptosis induced by etoposide and mitoxantrone in HL-60 cells. Proceedings of the American Association for Cancer Research Annual Meeting 37: 26

Wilens, T.E.; Biederman, J.; Baldessarini, R.J.; McDermott, S.P.; Puopolo, P.R.; Flood, J.G. 1992: Fluoxetine inhibits desipramine metabolism. Archives of General Psychiatry 49(9): 752

O'dell, B.M.; Frystak, K.J.; Paulson, D.R.; Miller, D.P. 1998: Fluoxetine injections produced differential effects on learning versus retention of the appetitive signaled barpress response. Society for Neuroscience Abstracts 24(1-2): 2123

Jenkins, J.; Shannon, M.W.; Woolf, A. 1990: Fluoxetine intoxication clinical course and serum concentrations. Veterinary and Human Toxicology 32(4): 348

Bodkin, J.A.; Teicher, M.H. 1989: Fluoxetine may antagonize the anxiolytic action of buspirone. Journal of Clinical Psychopharmacology 9(2): 150

Krishnan, A.; Hariharan, R.; Nair, S.A.; Pillai, M.R. 2008: Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochemical Pharmacology 75(10): 1924-1934

Chiang, W.K.; Smilkstein, M.J. 1989: Fluoxetine monoamine oxidase inhibitor interaction. Veterinary and Human Toxicology 31(4): 369

Matsumoto, K.; Uzunova, V.; Pinna, G.; Taki, K.; Uzunov, D.; Watanabe, H.; Guidotti, A.; Costa, E. 1998: Fluoxetine normalizes the social isolation-induced decrease of pentobarbital sleeping time by increasing brain allopregnanolone content. Society for Neuroscience Abstracts 24(1-2): 346

Beasley, C.M.Jr; Faries, D.E.; Sayler, M.E.; Potvin, J.H. 1991: Fluoxetine not associated with suicidality in international controlled clinical trials in depression. Clinical Research 39(3): 767A

Heiligenstein, J.H.; Coccaro, E.F.; Potvin, J.H.; Beasley, C.M.Jr; Dornseif, B.E.; Masica, D.N. 1991: Fluoxetine not associated with violent behavior in controlled clinical trials. Clinical Research 39(3): 768A

Carroll, M.E.; Lac, S.T.; Acensio, M.; Kragh, R. 1989: Fluoxetine or dietary l tryptophan reduce intravenous cocaine self administration in rats. FASEB Journal 3(3): A419

Rohrig, T.P.; Prouty, R.W. 1989: Fluoxetine overdose: a case report. Journal of Analytical Toxicology 13(5): 305-307

Bergstrom, R.F.; Beasley, C.M.Jr; Levy, N.B.; Dubey, A.K.; Blumenfield, M.; Goodman, A.; Solomon, R.J. 1991: Fluoxetine pharmacokinetics after daily doses of 20 mg fluoxetine in patients with severely impaired renal function. Pharmaceutical Research (New York) 8(10 Suppl): S924

Lowry, C.A.; Kedzie, K.A.; Renner, K.J.; Moore, F.L. 1993: Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and the serotonergic system. Society for Neuroscience Abstracts 19(1-3): 175

Pary, R.; Tobias, C.; Lippmann, S. 1989: Fluoxetine: prescribing guidelines for the newest antidepressant. Southern Medical Journal 82(8): 1005-1009

Upreti, V.V.; Eddington, N.D. 2008: Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat. Journal of Pharmaceutical Sciences 97(4): 1593-1605

Richardson, N.R.; Roberts, D.C.S. 1991: Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine in the rat. Society for Neuroscience Abstracts 17(1-2): 888

Bledsoe, S.; Zhou, F.C. 1997: Fluoxetine protects serotonergic fibers from degeneration by methamphetamine. Society for Neuroscience Abstracts 23(1-2): 1221

Beasley, C.M.; Bosomworth, J.C.; Wernicke, J.F. 1990: Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacology Bulletin 26(1): 18-24

Frey, J. 1990: Fluoxetine suppresses human cataplexy a pilot study. Neurology 40(4 Suppl 1): 135

Goldstein, D.J.; Sayler, M.E.; Rampey, A.H.; Roback, P.J. 1995: Fluoxetine therapy in patients with obesity and insulin-dependent diabetes mellitus. Clinical Pharmacology and Therapeutics 57(2): 200

Page, M.E.; Abercrombie, E.D. 1994: Fluoxetine treatment attenuates stress-induced norepinephrine efflux in the hippocampus. Society for Neuroscience Abstracts 20(1-2): 1446

Petrakis, I.; Carroll, K.; Gordon, L.; Cushing, G.; Rounsaville, B. 1994: Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study. Journal of Addictive Diseases 13(3): 25-32

Barak, Y.; Pinchas Hamiel, O.; Elizur, A.; Achiron, A. 1997: Fluoxetine treatment induces weight-loss in steroid dependent patients A pilot study in myasthenia gravis. Neurology 48(3 Suppl 2): A73

Batki, S.L.; Manfredi, L.B.; Murphy, J.M.; Washburn, A.M.; Jones, R.T. 1993: Fluoxetine treatment of cocaine abuse and depression in HIV-infected injection drug users. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 416

Makaric, G.; Folnegovic Smalc, V.; Mimica, N.; Folnegovic, Z. 1998: Fluoxetine treatment of de novo obsessive-compulsive symptoms in schizophrenia after clozapine treatment. Schizophrenia Research 29(1-2): 162

Judd, F.K.; Mijch, A.M.; Cockram, A. 1995: Fluoxetine treatment of depressed patients with HIV infection. Australian and New Zealand Journal of Psychiatry 29(3): 433-436

Sovner, R.; Fox, C.J.; Lowry, M.J.; Lowry, M.A. 1993: Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research: Jidr 37: 301-311

Levenson, J.L.; Fallon, H.J. 1993: Fluoxetine treatment of depression caused by interferon-alpha. American Journal of Gastroenterology 88(5): 760-761

Barak, Y.; Achiron, A.; Shoshani, D.; Elizur, A. 1998: Fluoxetine treatment of depression in patients suffering from multiple sclerosis. Human Psychopharmacology 13(1): 66-67

Goldstein, D.J.; Rampey, A.H.; Bray, G.A.; Gray, D. 1991: Fluoxetine treatment of obese patients with noninsulin dependent diabetes mellitus. Clinical Research 39(3): 767A

Platonova, N.; Voznesenskaya, T. 1998: Fluoxetine treatment of obesity. International Journal of Obesity 22(Suppl 3): S276

Menkes, D.B.; Taghavi, E.; Mason, P.A.; Spears, G.F.; Howard, R.C. 1992: Fluoxetine treatment of severe premenstrual syndrome. Bmj 305(6849): 346-347

Ricketts, R.W.; Goza, A.B.; Ellis, C.R.; Singh, Y.N.; Singh, N.N.; Cooke, J.C. 1993: Fluoxetine treatment of severe self-injury in young adults with mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry 32(4): 865-869

Uzunov, D.P.; Cheney, D.L.; Costa, F.; Guidotti, A. 1995: Fluoxetine treatment selectively causes brain accumulation of allopregnanolone in rats. Society for Neuroscience Abstracts 21(1-3): 1025

Cornelius, J.R.; Soloff, P.H.; Perel, J.M.; Ulrich, R.F. 1990: Fluoxetine trial in borderline personality disorder. Psychopharmacology Bulletin 26(1): 151-154

Cornelius, J.R.; Salloum, I.M.; Cornelius, M.D.; Perel, J.M.; Thase, M.E.; Ehler, J.G.; Mann, J.J. 1993: Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin 29(2): 195-199

Lum, L. 1991: Fluoxetine use in tourette syndrome. Canadian Journal of Hospital Pharmacy 44(6): 301

Jasovc Gasic, M.; Miljevic, C.; Crnobaric, C. 1997: Fluoxetine versus moclobemide in the treatment of dysthymic patients. European Psychiatry 12(Suppl 2): 211S

Cornelius, J.R.; Salloum, I.M.; Thase, M.E.; Haskett, R.F.; Moss, H.B.; Black, A. 1998: Fluoxetine versus placebo in depressed alcoholics A one-year follow-up. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 121A

Hauser, J.; Rybakowski, J.; Glodowska, A. 1998: Fluoxetine vs placebo-in two clusters of male alcoholics 1 year prospective study. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 178A

Phillips, S.; Heiligenstein, J.; Birkett, M.; Brent, J.; Kulig, K.; (Usa), A.S.udy Group 1994: Fluoxetine vs tricyclic antidepressants A prospective multicenter study of antidepressant drug overdoses. Veterinary and Human Toxicology 36(4): 378

Lauterbach, E.C. 1994: Fluoxetine withdrawal and thalamic pain. Neurology 44(5): 983-984

El Maanni, A.; Combourieu, I.; Bonini, M.; Creppy, E.E. 1993: Fluoxetine, an antidepressant, and norfluoxetine, its metabolite, determined by HPLC with a C8 column and ultraviolet detection. Clinical Chemistry 39(8): 1749-1750

Morton, W.A.; Sonne, S.C.; Lydiard, R.B. 1993: Fluoxetine-associated side effects and suicidality. Journal of Clinical Psychopharmacology 13(4): 292-295

Raviña, T.; Suarez, M.L.; Mendez-Castrillón, J. 1998: Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. International Journal of Cardiology 65(3): 311-313

Rudnick, A.; Modai, I.; Zelikovski, A. 1997: Fluoxetine-induced Raynaud's phenomenon. Biological Psychiatry 41(12): 1218-1221

Collu, M.; Poggiu, A.S.; Pani, L.; Serra, G. 1997: Fluoxetine-induced conditioned place preference: a preliminary study. Synapse 25(3): 309-311

Beer, K.; Albertini, J.; Medenica, M.; Busbey, S. 1994: Fluoxetine-induced hypersensitivity. Archives of Dermatology 130(6): 803-804

Schillinger, F.; Mathieu, Y.; Ferrer, M.; Montagnac, R.; Milcent, T. 1994: Fluoxetine-induced hyponatremia. Semaine des Hopitaux 70(27-28): 815-818

Van, D.K.r, L.D.; Li, Q.; Cabrera, T.M.; Pinto, W.; Battaglia, G. 1996: Fluoxetine-induced increase in G-protein coupling of hypothalamic 5-HT-2A/2C receptors Time course of adaptive changes. Society for Neuroscience Abstracts 22(1-3): 1777

Matray Devoti, J.; Widmer, D.; Cornille, C.; Wagner, G.C. 1996: Fluoxetine-induced increase in target biting but not resident-intruder attack. Society for Neuroscience Abstracts 22(1-3): 2066

Trillat, A.C.; Malagie, I.; Scearce, K.; Jacquot, C.; Hen, R.; Gardier, A.M. 1995: Fluoxetine-induced increases in frontocortical 5-HT levels A microdialysis study in mice lacking 5-HT-1B receptors. Society for Neuroscience Abstracts 21(1-3): 1369

Braitberg, G.; Curry, S. 1994: Fluoxetine-induced seizure after overdose. Veterinary and Human Toxicology 36(4): 372

Benazzi, F.; Mazzoli, M. 1994: Fluoxetine-induced sexual dysfunction: a dose-dependent effect?. Pharmacopsychiatry 27(6): 246

Vrtovsnik, F.; Bridoux, F.; Caron, J.; Hazzan, M.; Lemaitre, V.; Vanhille, P. 1993: Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion. Therapie 48(5): 513

Whittle, M.C.; Cookson, J.C. 1993: Fluphenazine decanoate and flupenthixol decanoate Can we predict dose levels in psychiatric outpatients?. Journal of Psychopharmacology (ABSTR BOOK): A52

Cano, C.; Jambor, L.; Grove, T.H. 1992: Fluphenazine in serum by gc ms. Clinical Chemistry 38(6): 1010

Marder, S.R.; Van Putten, T.; Aravagiri, M.; Hawes, E.M.; Hubbard, J.W.; McKay, G.; Mintz, J.; Midha, K.K. 1990: Fluphenazine plasma levels and clinical response. Psychopharmacology Bulletin 26(2): 256-259

Muller, W.E.G.; Pergande, G.; Ushijima, H.; Perovic, S. 1995: Flupirtine A neuroprotective agent that prevents injury by prion protein fragment and lead acetate. Society for Neuroscience Abstracts 21(1-3): 766

Friedel, H.A.; Fitton, A. 1993: Flupirtine. a review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45(4): 548-569

Mueller, W.E.G.; Perovic, S.; Schleger, C.; Pergande, G. 1994: Flupirtine inhibits apoptosis of rat cortical cells caused by NMDA and gp120. AIDS-Forschung 9(11): 603

Mueller, W.E.G.; Perovic, S.; Pergande, G.; Omoto, K.; Ushijima, H. 1996: Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate. Antiviral Research 30(1): A38

Mueller, W.E.G.; Perovic, S.; Schleger, C.; Behrend, K.; Pergande, G. 1994: Flupirtine prevents apoptosis induced in rat cortical cells by NMDA as well as by GP120 of HIV-1. Society for Neuroscience Abstracts 20(1-2): 451

Mueller, W.E.G.; Ushijima, H.; Pergande, G.; Perovic, S. 1996: Flupirtine protects neuronal cells against induced apoptosis in vitro Implications for treatment of Alzheimers disease, Creutzfeldt-Jakob disease and AIDS patients. Society for Neuroscience Abstracts 22(1-3): 2139

Bergk, A.; Lautenschlager, M.; Weih, M.; Harms, C.; Wiegand, F.; Dimagl, U. 1998: Flupirtine reduces cell death induced by oxygen-glucose-deprivation in primary neuronal cultures. Society for Neuroscience Abstracts 24(1-2): 1303

Schwarz, M.; Block, F.; Pergande, G.; Noth, J. 1996: Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats. Society for Neuroscience Abstracts 22(1-3): 2145

Bujon, G.; Herremans, L.; Phan, L. 1992: Flupol A Forecasting model for flow an pollutant discharge from sewerage systems during rainfall events. Water Science and Technology 25(8): 207-215

Parmigiani, S.; Palanza, P. 1991: Fluprazine inhibits intermale attack and infanticide, but not predation, in male mice. Neuroscience and Biobehavioral Reviews 15(4): 511-513

Puhl, T.; Leisse, N. 1996: Fluquinconazole, the first quinazole molecule in cereals. Laux, W, Communications from the Federal Biological Institute for Agriculture and Forestry Berlin-Dahlem, Mitteilungen aus der Biologischen Bundesanstalt fuer Land- und Forstwirtschaft Berlin-Dahlem: 500

Tracy, T.S.; Rosenbluth, B.W.; Wrighton, S.A.; Gonzalez, F.J.; Korzekwa, K.R. 1995: Flurbiprofen 4-hydroxylation by CYP2C9. Clinical Pharmacology and Therapeutics 57(2): 152

Alovisi, C.; Cereser, M. 1992: Flurbiprofen Opinions for comparison. Rivista di Patologia e Clinica 47(1): 1-16

Sargent, C.A.; Riemersma, R.A. 1990: Flurbiprofen and ischemic arrhythmias in isolated perfused rat hearts after feeding diets rich in linoleic acid la. Journal of Molecular and Cellular Cardiology 22(Suppl 3): S76

Letac, B.; Morand, P.; Brochier, M.; Monassier, J.P.; Castaigne, A.; Tadei, A.; Lardoux, H.; Jan, F.; Ceprim Coop Study Group 1991: Flurbiprofen as a preventive treatment after reperfusion in acute myocardial infarction. Journal of the American College of Cardiology 17(2 Suppl A): 167A

Perona, P.G.; Wezeman, F.H.; Light, T. 1994: Flurbiprofen as an inhibitor or reactive fibrous membrane surrounding joint arthroplasty components. Surgical Forum 45: 619-621

Abramson, M.M.; Wolff, L.F.; Aeppli, D.M.; Hardie, N.A.; Friedman, H. 1990: Flurbiprofen effect on prostaglandin thromboxane levels in human crevicular fluid. Journal of Dental Research 69(Special Issue): 219

Mahmud, T.; Sigthorsson, G.; Somasundaram, S.; Taveres, I.; Hutt, A.J.; Scott, D.L.; Bjarnason, I. 1996: Flurbiprofen enantiomers, COX inhibition and mitochondrial damage. Arthritis and Rheumatism 39(9 Suppl): S280

Dickie, B.G.M.; Davies, J.A. 1994: Flurbiprofen enhances potassium-evoked release of glutamate from rat cerebellum in vitro. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 169P

Camras, C.B.; Wang R F.; Podos, S.M. 1989: Flurbiprofen fl blocks the p aminoclonidine pac induced reduction of intraocular pressure iop in normotensive and glaucomatous monkey eyes. IOVS Investigative Ophthalmology and Visual Science 30(3): 98

Libert, E.; Glowacki, J. 1989: Flurbiprofen inhibits resorption of implanted bone particles in rats. Journal of Dental Research 68(Special Issue): 257

Severin, C.H.; Wang R F.; Camras, C.B.; Podos, S.M. 1990: Flurbiprofen inhibits the mk 927 induced reduction of intraocular pressure in glaucomatous monkey eyes. IOVS Investigative Ophthalmology and Visual Science 31(4): 233

Mccannel, C.; Koskela, T.; Brubaker, R.F. 1990: Flurbiprofen pretreatment does not block apraclonidines effect on aqueous flow. IOVS Investigative Ophthalmology and Visual Science 31(4): 148

Wunderlich, J C.; Schuster, O.; Lukas, H.; Schick, U. 1996: Flurbiprofen-containing immediate-effect medicament and its use. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2009

L.P.ge Degivry, M.T.; Garello, G. 1991: Fluridone induction of vivipary during sunflower seed development. Plant Physiology 96(1 Suppl): 158

Allegra, L.; Blasi, F.; Cosentini, R.; Cantoni, C.; Arosio, C.; Roma, E.; Bottaro, E.; Bossi, R. 1998: Flurithromycin treatment of Chlamydia pneumoniae infection in patients with chronic bronchitis. European Respiratory Journal 12(Suppl 28): 217S

Samoriski, G.M.; Applegate, C.D. 1993: Flurothyl kindling does not alter qualitative patterns of Fos immunoreactivity in C57BL/6J mice. Society for Neuroscience Abstracts 19(1-3): 605

Barr, R.; Chaney, W.R.; Crane, F.L. 1996: Flurprimidol and paclobutrazol affect electron transport in mitochondria. Molecular Biology of the Cell 7(Suppl ): 501A

Wall, D.A. 1992: Flurtamone for wild mustard control in canola. Weed Technology 6(4): 878-883

Furnish, G. 1996: Flush port for endoscopic surgical instruments. Official Gazette of the United States Patent and Trademark Office Patents 1183(1): 197-198

Wiles, Charles, E.IIi 1995: Flush resuscitation for toxic strep Syndrome Continuous hemodiafiltration for gas toxic shock. Blood Purification 13(6): 392

Mcarthur, G.R. 1998: Flush valve with cable attachment. Official Gazette of the United States Patent and Trademark Office Patents 1215(3): 2826-2827

Mcarthur, G.R. 1998: Flush valve with interlocking seal. Official Gazette of the United States Patent and Trademark Office Patents 1215(2): 1639

Schneider, B.L. 1996: Flush-interval indicator for soluble pouches. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2709

Churchill, P.C.; Churchill, M.C. 1998: Flush-storage solution for donor organs. Official Gazette of the United States Patent and Trademark Office Patents 1216(2): 1753

Keyes, D.E. 1998: Flushable ostomy pouch. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2051-2052

Keyes, D.E.; Johnsen, K. 1995: Flushable ostomy pouch with mechanical coupling. Official Gazette of the United States Patent and Trademark Office Patents 1170(2): 1075

Schneider, B.L.; Giori, C. 1995: Flushable pH-sensitive ostomy pouch containing its own pH-modifier. Official Gazette of the United States Patent and Trademark Office Patents 1174(4): 2513

Bohnert, T.J.; Reid, B.L.; Bennett, G.W. 1992: Flushing activity of insecticides 1991. Insecticide and Acaricide Tests : 377-378